{
  "meta": {
    "title": "00272_Mid_Day_Module_Pathology-2",
    "url": "https://brainandscalpel.vercel.app/00272-mid-day-module-pathology-2-49bf9eef.html",
    "scrapedAt": "2025-11-29T18:14:59.495Z"
  },
  "questions": [
    {
      "id": 14302,
      "choices": [
        {
          "id": 57169,
          "text": "<p><span style=\"font-size:16px;\">Hepcidin</span></p>"
        },
        {
          "id": 57170,
          "text": "<p><span style=\"font-size:16px;\">DMT1</span></p>"
        },
        {
          "id": 57171,
          "text": "<p><span style=\"font-size:16px;\">Ferroportin</span></p>"
        },
        {
          "id": 57172,
          "text": "<p><span style=\"font-size:16px;\">Ferritin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 45-year-old male with a history of hereditary hemochromatosis is being evaluated for his condition. Which of the following is considered the most important but nonspecific regulator of iron metabolism?</span></p>",
      "unique_key": "Q9204622",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578828,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A. Hepcidin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hepcidin is considered the most important but nonspecific regulator of iron metabolism. It's synthesized in the liver and plays a central role in systemic iron homeostasis.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. DMT1</strong> (Divalent metal transporter 1) is a specific transporter that moves ferrous iron across the apical membrane of enterocytes. While important for iron uptake, it has a more focused role.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Ferroportin</strong> is the protein responsible for exporting iron from cells into the plasma. It has a specific function and is regulated by hepcidin.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Ferritin</strong> is the primary intracellular iron storage protein and is a marker of iron stores but does not regulate iron metabolism directly.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hepcidin is the most important but nonspecific regulator of iron metabolism since it not only controls iron homeostasis but also has broader effects including antimicrobial activity and is influenced by various physiological and pathological conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Robbins 10th/ 652</strong></span></p>",
      "correct_choice_id": 57169,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14304,
      "choices": [
        {
          "id": 57177,
          "text": "<p><span style=\"font-size:12pt;\">Anti IgM</span></p>"
        },
        {
          "id": 57178,
          "text": "<p><span style=\"font-size:12pt;\">Anti IgG</span></p>"
        },
        {
          "id": 57179,
          "text": "<p><span style=\"font-size:12pt;\">IgM</span></p>"
        },
        {
          "id": 57180,
          "text": "<p><span style=\"font-size:12pt;\">Donath-Landsteiner antibody</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 52-year-old man presents with acrocyanosis and hemolysis after exposure to cold temperatures. His direct Coombs' test is positive with cold sub type of antibodies. Which of the following antibodies is most likely responsible for his condition?</span></p>",
      "unique_key": "Q6461646",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578830,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) IgM</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Clinical presentation given in the stem of the question is suggestive of Cold Agglutinin disease.</span></li><li><span style=\"font-size:16px;\">Cold hemagglutinin is associated with IgM antibodies. These are not to be confused with anti-IgM antibodies given as other option in the question.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A.&nbsp; Anti-IgM would imply</strong> an <strong>antibody against IgM&nbsp;</strong>itself, which is <strong>not&nbsp;</strong>the cause of <strong>cold hemagglutinin disease</strong>. Cold agglutinins are typically IgM antibodies that can agglutinate and lyse red blood cells at cold temperatures.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B.&nbsp; Anti-IgG suggests</strong> an <strong>antibody against IgG</strong>, which is <strong>not&nbsp;</strong>typically involved in <strong>cold hemagglutinin disease</strong>. IgG antibodies can, however, cause<strong> warm autoimmune hemolytic anemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Donath-Landsteiner antibody:</strong> The Donath-Landsteiner antibody is seen in paroxysmal cold hemoglobinuria..</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Cold agglutinin disease is characterised by IgM antibodies whereas PCH is characterised by Donath-Landsteiner (IgG antibodies against P-antigen on RBC surface)&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 649-50</strong></span></p>",
      "correct_choice_id": 57179,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14312,
      "choices": [
        {
          "id": 57209,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemolytic uremic syndrome</span></span></span></p>"
        },
        {
          "id": 57210,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polysplenia</span></span></span></p>"
        },
        {
          "id": 57211,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spherocytosis</span></span></span></p>"
        },
        {
          "id": 57212,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acanthocytosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child presents with acute renal failure, thrombocytopenia, and a microangiopathic hemolytic anemia after a diarrheal illness. A peripheral blood smear shows fragmented red cells, including helmet cells. Which condition is most consistent with these findings?</span></span></span></p>",
      "unique_key": "Q9708488",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578841,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Hemolytic uremic syndrome </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hemolytic uremic syndrome (HUS) </strong>often follows a<strong> diarrheal illness </strong>caused by certain strains of<strong> E. coli. </strong>It is characterized by the <strong>triad of acute renal failure, thrombocytopenia, and microangiopathic hemolytic anemia with schistocytes, </strong>including<strong> helmet cells </strong>on peripheral smear.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Polysplenia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a condition where <strong>multiple small spleens </strong>are present and is typically associated with <strong>congenital abnormalities</strong>; it does not characteristically present with schistocytes or helmet cells.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Spherocytosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a disorder causing <strong>spherically shaped red blood cells </strong>due to a defect in the<strong> RBC membrane, </strong>not typically associated with schistocytes or helmet cells.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Acanthocytosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> refers to <strong>spur cells with spiculated membranes</strong>, which are seen in<strong> liver disease and abetalipoproteinemia, </strong>among others, and does not present with helmet cells.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Helmet cells </strong>on a blood smear are characteristic of <strong>microangiopathic hemolytic anemias</strong>, such as those seen in<strong> hemolytic uremic syndrome (HUS), </strong>which can present with<strong> renal failure and thrombocytopenia </strong>following<strong> gastroenteritis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 662 </span></span></em></strong></p>",
      "correct_choice_id": 57209,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14272,
      "choices": [
        {
          "id": 57049,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalassemia major</span></span></span></p>"
        },
        {
          "id": 57050,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalassemia minor</span></span></span></p>"
        },
        {
          "id": 57051,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron deficiency anemia</span></span></span>​</p>"
        },
        {
          "id": 57052,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia of chronic disease</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old female presents with the following laboratory values: hemoglobin 9gm%, MCV is 55%, RBC is 4.5 million/mm3. There is no history of blood transfusion. What is the most likely diagnosis out of the following?</span></span></span></p>",
      "unique_key": "Q8775889",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578805,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Thalassemia minor </span></em></strong></span></span></p>\r\n\r\n<p>&nbsp;&nbsp;<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thalassemia major </strong>patient presents with <strong>severe anemia and cannot survive without blood transfusion, </strong>so this option can be easily ruled out. For other options, <strong>Mentzer index </strong>is useful for <strong>differentiating between thalassemia minor and iron deficiency anemia. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;&nbsp;<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thalassemia minor </strong>often presents with <strong>mild to moderate anemia </strong>and a <strong>low MCV. </strong>The <strong>Mentzer index</strong>, calculated as <strong>MCV </strong>divided by the <strong>RBC count</strong>, is less than <strong>13 in thalassemia minor.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Patients with thalassemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>major </strong>typically present with <strong>severe anemia</strong> requiring regular<strong> blood transfusions. </strong>The degree of anemia in the <strong>vignette</strong> is not consistent with thalassemia major.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Iron deficiency anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically presents with<strong> microcytic and hypochromic anemia</strong>. The<strong> Mentzer index </strong>is generally <strong>greater than 13</strong>, which is not the case here.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Anemia of chronic disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> usually presents with <strong>normocytic or sometimes microcytic anemia</strong>, but it is often characterized by a<strong> normal or increased storage iron level</strong>, which can be evaluated by <strong>serum ferritin.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When presented with<strong> mild to moderate microcytic anemia </strong>and an <strong>MCV/RBC count </strong>that yields a <strong>Mentzer index of less than 13, thalassemia minor </strong>is a likely diagnosis. </span></span></p>",
      "correct_choice_id": 57050,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14268,
      "choices": [
        {
          "id": 57033,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta thalassemia trait</span></span></span></p>"
        },
        {
          "id": 57034,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></span></p>"
        },
        {
          "id": 57035,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hereditory spherocytosis</span></span></span></p>"
        },
        {
          "id": 57036,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6 PD deficiency</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 24-year-old woman presents with mild anemia noted on routine screening. She reports a family history of anemia but has no significant personal medical history. She denies any symptoms of anemia. A hemoglobin electrophoresis is performed, showing an increased HbA2 level. Which of the following is the most likely diagnosis?</span></span></span></span></span></p>",
      "unique_key": "Q9765507",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578801,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Beta thalassemia trait </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Beta thalassemia trait is characterized by a mutation in the beta-globin gene, leading to reduced (&beta;+) or absent (&beta;0) production of &beta;-globin chains. Compensatory increase in HbA2 (&alpha;2&delta;2) is a hallmark of this condition.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Hemoglobin electrophoresis usually reveals an increase in HbA2 (&alpha;2&delta;2) to 4% to 8% of the total hemoglobin (nor&not;mal, 2.5% &plusmn; 0.3%), which is a reflection of an elevated ra&not;tio of &delta;-chain to &beta;-chain synthesis. HbF levels are generally normal or occasionally slightly increased</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Sickle cell anemia</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> is characterized by a mutation in the beta-globin gene that leads to the production of hemoglobin S. Hemoglobin electrophoresis in sickle cell anemia typically shows a predominance of HbS and possibly elevated HbF but not HbA2.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C. Hereditary spherocytosis</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> is a disorder of the red blood cell membrane leading to spherical erythrocytes and hemolytic anemia. It does not involve abnormalities in hemoglobin synthesis or elevated HbA2 levels.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. G6PD deficiency</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> is an X-linked enzymatic defect leading to hemolytic anemia under conditions of oxidative stress. It is not associated with an increase in HbA2 on electrophoresis.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong><u> </u></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">When a hemoglobin electrophoresis reveals increased HbA2 levels, it is indicative of beta thalassemia trait, reflecting an imbalance in globin chain production. </span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<em> Robbins 10<sup>th</sup>/ 641 </em></span></span><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></em></strong></p>",
      "correct_choice_id": 57033,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15329,
      "choices": [
        {
          "id": 61276,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute myeloid leukemia </span></span></span></p>"
        },
        {
          "id": 61277,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute lymphoblastic leukemia </span></span></span></p>"
        },
        {
          "id": 61278,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic myelogenous leukemia </span></span></span></p>"
        },
        {
          "id": 61279,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myelodysplastic syndrome </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A peripheral smear with increased neutrophils, basophils, eosinophils, and platelets is highly suggestive of:</span></span></span></p>",
      "unique_key": "Q2152030",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578831,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Chronic myelogenous leukemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chronic Myelogenous Leukemia (CML):</strong> is characterized by the presence of the<strong> Philadelphia chromosome</strong>, resulting in the constitutive activation of the <strong>BCR-ABL1 tyrosine kinase</strong>. This leads to<strong> increased production of myeloid cells,</strong> including <strong>neutrophils,</strong> <strong>basophils, eosinophils, and platelets.</strong> The peripheral smear in CML often shows a <strong>&quot;left-shift,&quot; </strong>with <strong>increased mature and immature myeloid cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Acute Myeloid Leukemia (AML):</strong> is characterized by the <strong>rapid growth </strong>of <strong>abnormal myeloid cells </strong>in the bone marrow. While AML may show <strong>increased myeloid cells </strong>in the peripheral smear, it typically presents with<strong> blasts and a decrease in mature cells</strong>, unlike the broad spectrum of increased cells seen in the question.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Acute Lymphoblastic Leukemia (ALL):</strong> <strong>primarily affects lymphoid cells</strong>. It is characterized by the presence of <strong>lymphoblasts </strong>in the peripheral blood. The question describes an increase in myeloid cell lineages (neutrophils, basophils, eosinophils, and platelets), making ALL less likely.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Myelodysplastic Syndrome (MDS):</strong> is a<strong> group of disorders </strong>characterized by <strong>ineffective hematopoiesis</strong>. While MDS can present with<strong> cytopenias and dysplastic </strong>changes in blood cells, the specific pattern described in the question (increased neutrophils, basophils, eosinophils, and platelets) is more indicative of CML.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chronic myeloid leukemia </strong>is a<strong> stem cell disease</strong> that is characterized by <strong><em>leukocytosis with granulocytic immaturities, basophilia, splenomegaly</em></strong> and distinct chromosomal abnormality<strong> Philadelphia chromosome</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 622) </span></span></em></strong></p>",
      "correct_choice_id": 61278,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14311,
      "choices": [
        {
          "id": 57205,
          "text": "<p><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgG </span></span></p>"
        },
        {
          "id": 57206,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgM</span></span></p>"
        },
        {
          "id": 57207,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgA</span></span></p>"
        },
        {
          "id": 57208,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgD</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with acrocyanosis and hemolytic anemia after exposure to cold weather. Laboratory tests reveal agglutination of red blood cells at temperatures between 4 to 6&deg;C. Which type of immunoglobulin is most likely responsible for this agglutination?</span></span></span></p>",
      "unique_key": "Q3798098",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578838,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. IgM </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cold agglutinins </strong>are<strong> monoclonal IgM antibodies </strong>that react at<strong> 4 to 6&deg;C</strong>. They are called <strong>agglutinins </strong>because the <strong>IgM directed against the &lsquo;I&rsquo; antigen </strong>present on the RBCs can <strong>agglutinate red cells </strong>due to its large size <strong>(pentamer).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IgM antibodies </strong>are known as <strong>cold agglutinins </strong>and are the <strong>primary antibodies </strong>involved in <strong>cold agglutinin disease</strong>. They have a <strong>pentameric structure </strong>that allows them to <strong>effectively bridge and agglutinate red blood cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. IgG antibodies</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are generally involved in<strong> warm autoimmune hemolytic anemias </strong>and do not typically cause agglutination at low temperatures.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. IgA antibodies</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are mainly<strong> secretory antibodies </strong>and do not usually cause agglutination of red blood cells in cold environments.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. IgD antibodies</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are found in <strong>very low concentrations in serum </strong>and are not associated with cold agglutination of red blood cells.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IgM antibodies</strong>, known as <strong>cold agglutinins</strong>, can cause <strong>agglutination of red blood cells </strong>at <strong>low temperatures</strong>, as seen in <strong>cold agglutinin disease</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></em></strong><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 648 </span></em></strong></span></span></p>",
      "correct_choice_id": 57206,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41793,
      "choices": [
        {
          "id": 166856,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clumps of RBCs due to IgM mediated cold autoim&shy;mune haemolytic anemia</span></span></span></p>"
        },
        {
          "id": 166857,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clumps of RBCs due to IgG mediated warm auto&shy;immune haemolytic anemia</span></span></span></p>"
        },
        {
          "id": 166858,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RBC lysis due to hemoglobinopathy</span></span></span></p>"
        },
        {
          "id": 166859,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clumps of RBCs due to IgG mediated cold autoim&shy;mune haemolytic anemia</span></span></span>​​​​​​</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year‑old female presents in the month of December with chronic fatigue and cyanosis of nose with blue lips. A peripheral blood smear showed the following image. What is the most likely cause of the findings seen? </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/26/picture1_67TV6O2.jpg\" style=\"height:198px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q5754262",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578813,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Clumps of RBCs due to IgM mediated cold autoimmune haemolytic anemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shows<strong> agglutinated red cells</strong>. Since the his&not;tory mentions that <strong>cyanosis </strong>is seen affecting <strong>fingers and tips of nose </strong>in the <strong>month of December</strong>, it suggests that the<strong> red cells agglutinated with cold antibody </strong>associated <strong>autoimmune haemolytic anemia</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cold autoimmune</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> hemolytic anemia (CAHA) is caused by<strong> IgM antibodies </strong>that <strong>agglutinate red blood cells at low temperatures. </strong>This typically happens in the<strong> cooler peripheral parts of the body </strong>and can lead to symptoms like <strong>cyanosis </strong>when the patient is exposed to <strong>cold environments</strong>. The condition can cause<strong> chronic fatigue due to anemia </strong>resulting from the <strong>destruction of agglutinated red blood cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp;&nbsp; </span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Warm autoimmune</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> hemolytic anemia (WAIHA) involves<strong> IgG antibodies </strong>that react with red blood cells<strong> at body temperature, </strong>leading to their destruction by the<strong> spleen</strong>. This would not typically be associated with cold exposure and is not consistent with the symptom of cyanosis, which is related to cold.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hemoglobinopathies,</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> such as <strong>sickle cell disease</strong>, can cause <strong>hemolytic anemia</strong>, but the <strong>red blood cells do not clump in</strong> <strong>response to cold.</strong> Instead, hemoglobinopathies typically involve<strong> structural abnormalities of the hemoglobin molecule itself.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cold agglutinin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> disease can <strong>sometime</strong>s involve <strong>IgG antibodies</strong>, but it is<strong> more commonly associated with IgM antibodies.</strong> IgG-mediated hemolysis at cold temperatures is much less common and would not explain the typical clumping seen in CAHA.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is important to recognize the clinical and laboratory findings consistent with <strong>cold autoimmune hemolytic anemia (CAHA), </strong>where <strong>IgM antibodies bind to red blood cells at low temperatures</strong>, causing them <strong>to agglutinate</strong>. This can lead to<strong> hemolytic anemia</strong>, resulting in symptoms such as<strong> chronic fatigue and cyanosis </strong>upon cold exposure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 643-4</span></span></em></strong></p>",
      "correct_choice_id": 166856,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15307,
      "choices": [
        {
          "id": 61188,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paroxysmal nocturnal haemoglobinuria </span></span></span></p>"
        },
        {
          "id": 61189,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aplastic anaemia </span></span></span></p>"
        },
        {
          "id": 61190,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paroxysmal cold haemoglobinuria </span></span></span></p>"
        },
        {
          "id": 61191,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myelodysplastic syndrome </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the least likely to be a pre-leukaemic condition? <em>&nbsp;</em></span></span></span></p>",
      "unique_key": "Q8709888",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578817,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Paroxysmal cold haemoglobinuria </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>PCH (paroxysmal cold hemoglobinu&shy;ria) </strong>is an <strong>autoimmune haemolytic anemia </strong>due to <strong>IgG autoanti&shy;bodies </strong>which bind to<strong> P blood group antigen </strong>and cause<strong> intravascu&shy;lar hemolysis and hemoglobinuria</strong>. Most cases are seen in <strong>children </strong>and have <strong>recovery within a month</strong>. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: &ldquo;PNH:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> about <strong>5% to 10% </strong>of patients eventually develop <strong>acute myeloid leukemia or a my&shy;elodysplastic syndrome</strong>, possibly because<strong> hematopoietic stem cells </strong>have suffered some type of<strong> genetic damage</strong>&rsquo;. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp; </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aplastic anemia </strong>results from a fundamental <strong>stem cell defect </strong>supported by the presence of<strong> karyotypic aberrations </strong>in many cases; the occasional trans&shy;formation of <strong>aplasia into myeloid neoplasms</strong>, typically <strong>myelodysplasia or acute myeloid leukemia; </strong>and the asso&shy;ciation with abnormally <strong>short telomeres</strong>. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The term <strong>&ldquo;myelodysplastic syndrome&rdquo; </strong>(MDS) refers to a group of <strong>clonal stem cell disorders </strong>characterized by<strong> maturation defects </strong>that are associated with<strong> ineffective hematopoiesis </strong>and a <strong>high risk of transformation to AML</strong>. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Paroxysmal Cold Hemoglobinuria (PCH) </strong>is primarily an <strong>autoimmune hemolytic anemia </strong>and <strong>not commonly </strong>associated with <strong>transformation to leukemia</strong>, which makes it the<strong> least likely condition to be pre-leukemic</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 545) </span></span></em></strong><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></p>",
      "correct_choice_id": 61190,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14303,
      "choices": [
        {
          "id": 57173,
          "text": "<p><span style=\"font-size:12pt;\">Spectrin</span></p>"
        },
        {
          "id": 57174,
          "text": "<p><span style=\"font-size:12pt;\">Defect in complement activating proteins</span></p>"
        },
        {
          "id": 57175,
          "text": "<p><span style=\"font-size:12pt;\">Defective GPI anchor</span></p>"
        },
        {
          "id": 57176,
          "text": "<p><span style=\"font-size:12.0pt;\">Mannose-binding residue effect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 30-year-old male presents with dark urine in the morning and has been found to have hemolytic anemia on laboratory evaluation. A diagnostic test reveals increased sensitivity of his red blood cells to lysis in acidified serum. Which of the following underlying defects is most consistent with these findings?</span></p>",
      "unique_key": "Q6543400",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578829,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Defective GPI anchor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ham’s acidified </strong>serum test is used for the diagnosis of <strong>paroxysmal nocturnal hemoglobinuria (PNH). </strong>In this condition, <strong>defective GPI anchor </strong>prevents the attachment of <strong>CD55, CD59 and C8 binding protein</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A <strong>defective GPI (glycosylphosphatidylinositol) </strong>anchor leads to<strong> paroxysmal nocturnal hemoglobinuria (PNH) </strong>by failing to secure protective proteins such as<strong> CD55 and CD59 to the cell membrane</strong>, leaving<strong> red blood cells </strong>susceptible to<strong> complement-mediated lysis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Spectrin is a cytoskeletal protein</strong> that helps maintain the<strong> red blood cell's shape</strong>. Defects in spectrin can cause <strong>hereditary spherocytosis </strong>but are not associated with increased red cell lysis in acidified serum.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B.</strong> <strong>Defect in complement activating proteins:</strong> PNH is due to complement regulatory (inhibitory) proteins not because of complement activating proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. The Mannose-binding lectin</strong> pathway is involved in <strong>innate immunity </strong>and can lead to<strong> opsonization and phagocytosis </strong>of pathogens, but defects here do not lead to the clinical picture described.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A<strong> defective GPI anchor </strong>is implicated in<strong> paroxysmal nocturnal hemoglobinuria (PNH), </strong>a condition that can be diagnosed with the <strong>Ham test</strong>, indicating <strong>increased red blood cell lysis </strong>in acidified serum due to<strong> increased complement sensitivity.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 645</strong></span></p>",
      "correct_choice_id": 57175,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15293,
      "choices": [
        {
          "id": 61132,
          "text": "<p><span style=\"font-size:12pt;\">Burkitt’s lymphoma</span></p>"
        },
        {
          "id": 61133,
          "text": "<p><span style=\"font-size:12pt;\">Acute erythroblastic leukemia</span></p>"
        },
        {
          "id": 61134,
          "text": "<p><span style=\"font-size:12pt;\">Acute megakaryocytic leukemia</span></p>"
        },
        {
          "id": 61135,
          "text": "<p><span style=\"font-size:12pt;\">Acute undifferentiated leukemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Myelofibrosis leading to a dry tap on bone marrow aspiration is seen with which of the following conditions?</span></p>",
      "unique_key": "Q3189302",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578802,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Acute megakaryocytic leukemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Acute megakaryocytic leukemia </strong>is a<strong> subtype of AML </strong>characterized by the proliferation of<strong> megakaryocytic precursors</strong>. This condition <i><strong>can lead to fibrosis in the bone marrow</strong></i>. As a consequence, a <strong>dry tap on bone marrow aspiration </strong>may occur due to the<strong> increased fibrous tissue</strong>. Therefore, this option is associated with<strong> myelofibrosis and a dry tap</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong> <strong>Burkitt’s lymphoma </strong>is a type of <strong>non-Hodgkin lymphoma</strong> that primarily involves<strong> B cells.</strong> It typically presents with <strong>rapidly</strong> <strong>growing tumors</strong>, often in the <strong>jaw or abdomen</strong>. Bone marrow involvement in Burkitt's lymphoma is uncommon. While <strong>bone marrow</strong> examination may reveal<strong> lymphoma cells</strong>, it is <strong>not </strong>typically associated with <strong>myelofibrosis, and a dry tap </strong>is not a characteristic finding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>Acute erythroblastic leukemia (erythroleukemia) </strong>is a rare<strong> subtype of acute myeloid leukemia (AML) </strong>characterized by the <strong>proliferation of immature erythroid precursors</strong>. This condition can<strong> infiltrate the bone marrow</strong>, leading to a<strong> hypercellular marrow </strong>with an excess o<strong>f erythroid precursors</strong>. Myelofibrosis and dry tap are not typical features of acute erythroblastic leukemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: Acute undifferentiated leukemia </strong>refers to a<strong> subtype of acute leukemia </strong>in which the <strong>blasts (immature cells) </strong>in the bone marrow<strong> lack specific features </strong>that would allow classification into<strong> myeloid or lymphoid lineages. </strong>While<strong> acute leukemias </strong>can sometimes be associated with <strong>bone marrow fibrosis</strong>, the <strong>dry tap is not </strong>typically a defining feature of this <strong>subtype.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Acute megakaryocytic leukemia</strong>, a <strong>subtype of acute myeloid leukemia</strong> characterized by the <strong>proliferation of megakaryocytic</strong> <strong>precursors</strong>, is associated with the <strong>development of myelofibrosis</strong> within the bone marrow, which can lead to a '<strong>dry tap' </strong>during<strong> bone</strong> <strong>marrow aspiration due to increased fibrous tissue.</strong></span></p>",
      "correct_choice_id": 61134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14292,
      "choices": [
        {
          "id": 57129,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchogenic cancer </span></span></span></p>"
        },
        {
          "id": 57130,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thymoma </span></span></p>"
        },
        {
          "id": 57131,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-Hodgkin lymphoma </span></span></span></p>"
        },
        {
          "id": 57132,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Squamous cell carcinoma </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly female with mediastinal mass undergoes a microscopic examination showing red cell aplasia. What is the likely diagnosis? </span></span></span></p>",
      "unique_key": "Q5311941",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578821,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. &nbsp;Thymoma </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The description of an <strong>elderly female with a mediastinal mass </strong>and microscopic examination showing<strong> red cell aplasia </strong>is suggestive of a<strong> thymoma</strong>. <strong>Thymomas </strong>are tumors arising from the <strong>thymic epithelial cells</strong> in the thymus, which is located in the <strong>mediastinum.</strong>&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thymomas</strong> can be associated with various<strong> paraneoplastic syndromes</strong>, and one of them is <strong>pure red cell aplasia.</strong>&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct lines from Robbins. &ldquo;In addition to <strong>myasthenia gravis</strong>, <strong>thymomas </strong>may be associated with <strong>several other paraneoplastic syndromes.</strong> These include in rough order of frequency, <strong>pure red cell aplasia, hypogammaglobulinemia, and multi organ autoimmunity</strong>&rdquo;. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thymoma </strong>is a <strong>tumor of the thymic epithelial cells </strong>and can present as a <strong>mediastinal mass</strong>. It is associated with <strong>several paraneoplastic syndromes </strong>including <strong>pure red cell aplasia</strong>, which leads to <strong>severe anemia due to the failure of the bone marrow to produce red blood cells</strong>, <strong>myasthenia gravis, hypogammaglobulinemia, and multi-organ autoimmunity.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Bronchogenic cancer</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> often presents as a <strong>mediastinal mass</strong>, especially in <strong>smokers</strong>. However, it is not commonly associated with red cell aplasia, but rather with other<strong> paraneoplastic syndromes such as hypercalcemia (due to production of PTH-related protein) or the secretion of ADH or ACTH.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Non-Hodgkin lymphoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can present as a<strong> mediastinal mass</strong>. It may cause <strong>bone marrow </strong>involvement leading to various <strong>cytopenias </strong>but is<strong> not </strong>specifically associated with<strong> pure red cell aplasia</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Squamous cell carcinoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically arises from the<strong> epithelial cells of the skin or mucous membranes </strong>and is not commonly found within the mediastinum. It is associated with <strong>paraneoplastic syndromes</strong>, but not typically with red cell aplasia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thymoma </strong>is the likely diagnosis in an elderly patient with a <strong>mediastinal mass and red cell aplasia, as thymomas </strong>are associated with this condition and other<strong> paraneoplastic syndromes </strong>such as <strong>myasthenia gravis, hypogammaglobulinemia, and multi-organ autoimmunity. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p493 </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"> </span></em></strong></span></span></p>",
      "correct_choice_id": 57130,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14291,
      "choices": [
        {
          "id": 57125,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myelodysplasia</span></span></p>"
        },
        {
          "id": 57126,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aplastic anemia</span></span></span>​​​​​​</p>"
        },
        {
          "id": 57127,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ITP</span></span></p>"
        },
        {
          "id": 57128,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PNH</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old with history of recurrent infection and bleeding gums. On investigations the patient had pancytopenia and the peripheral smear showed macrocytes. The bone marrow biopsy showed no megakaryocytes and filled with fat globules. What is your diagnosis? </span></span></span></p>",
      "unique_key": "Q3370656",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578820,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. &nbsp;Aplastic anemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical presentation of a<strong> 12-year-old </strong>with <strong>recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral</strong> <strong>smear, absence of megakaryocytes in bone marrow,</strong> and the<strong> presence of fat globules </strong>in the bone marrow biopsy is suggestive of <strong>aplastic anemia.&nbsp;</strong></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aplastic anemia </strong>is characterized by a <strong>deficiency of all blood cell types (pancytopenia) </strong>due to <strong>bone marrow failure</strong>. The <strong>absence of megakaryocytes </strong>in the bone marrow biopsy indicates a<strong> lack of platelet precursors, </strong>which can lead to <strong>bleeding manifestations</strong>. The presence of<strong> fat globules </strong>suggests replacement of<strong> hematopoietic cells by adipose tissue </strong>in the bone marrow.</span></span></span></p>\r\n\r\n<p><u><strong>EXPLANATION:</strong></u></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option A. Myelodysplastic syndromes :</strong>may also present with <strong>cytopenias and dysplastic </strong>changes in the bone marrow, but the <strong>absence of megakaryocytes </strong>and the<strong> presence of fat globules are not typical features.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C. ITP:&nbsp;</strong>is characterized by<strong> isolated thrombocytopenia </strong>without affecting other cell lines. It does not typically present with pancytopenia or the absence of megakaryocytes in the bone marrow.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option D. PNH:&nbsp;&nbsp;</strong>is characterized by <strong>hemolysis, </strong>often presenting with <strong>hemoglobinuria. </strong>However, it is <strong>not typically </strong>associated with <strong>pancytopenia and fat globules in the bone </strong>marrow.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation of<strong> recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral smear, absence of megakaryocytes in bone marrow</strong>, and <strong>presence of fat globules </strong>in bone marrow biopsy is indicative of<strong> aplastic anemia</strong>. This diagnosis is supported by the<strong> bone marrow biopsy </strong>findings showing a <strong>lack of megakaryocytes, indicative of platelet precursor deficiency, </strong>and <strong>fat globules </strong>suggesting the replacement of <strong>hematopoietic cells by adipose tissue</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/458</span></span></strong></p>",
      "correct_choice_id": 57126,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13671,
      "choices": [
        {
          "id": 54645,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It uses the complement receptor CD21 to attach and infect B cells </span></span></span></span></p>"
        },
        {
          "id": 54646,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is implicated in B-cell lymphomas in immunosuppressed people</span></span></span></span></p>"
        },
        {
          "id": 54647,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a potent inducer of B-cell growth and transformation </span></span></span></span></p>"
        },
        {
          "id": 54648,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EBV infection always results in Burkitt lymphoma</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old male presents with fever, sore throat, and lymphadenopathy. Serological tests are positive for Epstein-Barr virus (EBV) infection. Which of the following statements about the pathophysiology of EBV is incorrect?</span></span></p>",
      "unique_key": "Q6378393",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578835,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) EBV infection always results in Burkitt lymphoma</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EBV infection always leads to the development of Burkitt lymphoma.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>incorrect. </strong>While <strong>EBV </strong>is associated with <strong>Burkitt</strong> <strong>lymphoma,</strong> not everyone infected with<strong> EBV </strong>will develop this type of<strong> lymphoma.</strong> The association is <strong>strong in endemic areas</strong>, but the majority of<strong> EBV infections result in infectious mononucleosis or are asymptomatic.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It uses the complement receptor CD21 to attach and infect B cells.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>correct. EBV </strong>uses the <strong>CD21 receptor</strong>, which is the <strong>complement receptor on B cells, to infect them</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It is implicated in B-cell lymphomas in individuals with immunosuppression.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>True. EBV </strong>is associated with various<strong> B-cell lymphomas, </strong>especially in individuals who are<strong> immunosuppressed, </strong>such as those with<strong> HIV or post-transplant patients.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It is a potent inducer of B-cell growth and transformation.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>correct. EBV </strong>can drive<strong> B-cell growth and transformation</strong>, contributing to the development of diseases like <strong>infectious mononucleosis and</strong>, in some cases, <strong>B-cell lymphomas.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>EBV infection does not </strong>always lead to <strong>Burkitt lymphoma</strong>. While<strong> EBV </strong>can infect<strong> B cells </strong>and is associated with <strong>various lymphomas, </strong>the outcome of infection ranges from<strong> asymptomatic to infectious mononucleosis, </strong>with only a <strong>minority progressing to Burkitt lymphoma </strong>or other types of<strong> B-cell lymphoma.</strong></span></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>: Robbins and Cotran pathologic basis of disease 10th edition page: 326</span></span></strong></span></span></p>",
      "correct_choice_id": 54648,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14263,
      "choices": [
        {
          "id": 57013,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased reticulocyte count</span></span></span></p>"
        },
        {
          "id": 57014,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Raised Bilirubin</span></span></span></p>"
        },
        {
          "id": 57015,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild splenomegaly</span></span></span></p>"
        },
        {
          "id": 57016,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nucleated RBC</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 52-year-old male presents with fatigue, light-headedness, and a beefy-red tongue. Laboratory tests show macrocytosis and hypersegmented neutrophils. Which of the following laboratory findings is inconsistent with untreated megaloblastic anemia?</span></span></span></span></span></p>",
      "unique_key": "Q4204689",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578796,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Increased reticulocyte count </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An <strong>increased reticulocyte count </strong>is not a feature of <strong>untreated megaloblastic anemia</strong>. In megaloblastic anemia, the <strong>reticulocyte count is typically low </strong>because of <strong>ineffective erythropoiesis</strong>. However, the count <strong>increases once treatment with vitamin B12</strong> and <strong>folate</strong> is initiated, reflecting a response to treatment.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Raised bilirubin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> levels can be seen in <strong>megaloblastic anemia</strong> due to<strong> increased destruction of defective erythroid precursor</strong> <strong>cells in the bone marrow, </strong>which release <strong>bilirubin</strong> into the blood.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Mild splenomegaly</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> may be observed in <strong>megaloblastic anemia </strong>as the spleen works to <strong>filter the abnormal cells </strong>from the <strong>bloodstream.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. The presence</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of <strong>nucleated RBCs </strong>in the peripheral blood smear is a sign of<strong> severe anemia</strong>, including<strong> megaloblastic anemia</strong>, where<strong> immature and abnormal erythroid precursor cells </strong>are released into the bloodstream.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in <strong>untreated megaloblastic anemia</strong>, the<strong> reticulocyte count is low due to impaired DNA synthesis</strong> and <strong>ineffective erythropoiesis.</strong> An <strong>increased reticulocyte count</strong> after initiating treatment with<strong> vitamin B12 and folate supplementation</strong> indicates a positive response to therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<em> Robbins 10<sup>th</sup>/ 645, Wintrobe&rsquo;s 12th/1151-3 </em></span></span><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></em></strong></p>",
      "correct_choice_id": 57013,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14258,
      "choices": [
        {
          "id": 56993,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Iron deficiency anemia</span></p>"
        },
        {
          "id": 56994,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Megaloblastic anemia</span></p>"
        },
        {
          "id": 56995,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Anemia of chronic disease</span>​​​</p>"
        },
        {
          "id": 56996,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hereditary spherocytosis</span></p>"
        }
      ],
      "text": "<p><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">A 16-year-old male presents with jaundice and anemia. His blood smear shows spherical red blood cells, and laboratory tests reveal an increase in mean corpuscular hemoglobin concentration (MCHC). Which of the following is the most likely cause of his anemia?</span></p>",
      "unique_key": "Q1106309",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578793,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. &nbsp;Hereditary spherocytosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hereditary spherocytosis is a<strong> genetic disorder </strong>characterized by a defect in the<strong> red blood cell membrane</strong>, leading to a <strong>spherical or spheroid shape</strong>. Due to the <strong>loss of membrane surface area</strong>, the concentration of hemoglobin within the <strong>smaller, more compacted cells </strong>is increased, resulting in an <strong>elevated MCHC</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Elevated MCHC is a characteristic feature of spherocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Iron deficiency anemia:&nbsp;</strong>It is characterized by a <strong>decrease in the amount of hemoglobin </strong>in red blood cells, leading to a <strong>decreased MCHC</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Megaloblastic anemia:&nbsp;</strong>It can be associated with <strong>vitamin B12 or folate deficiency </strong>and ha<strong>s macrocytosis</strong>. This condition is associated with a<strong> normal or decreased MCHC.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Anemia of chronic disease:&nbsp;</strong>The anomie is often <strong>normocytic and normochromic</strong>, with a <strong>normal MCH</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Hereditary spherocytosis </strong>often presents with an<strong> elevated MCHC </strong>due to the <strong>spherical shape of red blood cells</strong>, which concentrates the <strong>haemoglobin content</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 639</strong></span></p>",
      "correct_choice_id": 56996,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13666,
      "choices": [
        {
          "id": 54625,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HNPCC </span></span></span></span></p>"
        },
        {
          "id": 54626,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gorlin syndrome </span></span></span></span></p>"
        },
        {
          "id": 54627,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Von Hipplel - Lindau syndrome </span></span></span></span></p>"
        },
        {
          "id": 54628,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peutz Jeghers syndrome</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old man presents with anemia and abdominal pain. On examination, he has pigmented macules over the palms, soles, and oral mucosa. Further investigations reveal loss-of-function mutations of the STK11 gene. What is the most probable diagnosis?</span></span></p>",
      "unique_key": "Q1660310",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578832,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Peutz Jeghers syndrome</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given scenario is suggestive of<strong> Peutz Jeghers syndrome</strong>. It is an<strong> autosomal-dominant disorder </strong>due to loss of function mutations of<strong> STK11</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is associated with <strong>arborizing polyps </strong>of the<strong> gastrointestinal tract (small intestine &gt; colon &gt; stomach). </strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It <strong>increases the risk of multiple epithelial cancers, </strong>particularly of<strong> colon, breast, lung, pancreas, and thyroid.</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Peutz-Jeghers syndrome </strong>is an <strong>autosomal dominant genetic disorder </strong>characterized by the development of<strong> benign polyps in the gastrointestinal tract and distinctive mucocutaneous hyperpigmentation</strong>. It is caused by mutations in the <strong>STK11 gene</strong>, which increase the risk of several <strong>epithelial cancers</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. HNPCC:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HNPCC, also known as <strong>Lynch syndrome</strong>, is an <strong>autosomal dominant condition </strong>predisposing individuals to<strong> early-onset colorectal cancer and other malignancies</strong>. It is associated with <strong>mutations in mismatch repair genes, </strong>not STK11.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Gorlin syndrome:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gorlin syndrome, or<strong> nevoid basal cell carcinoma syndrome</strong>, is characterized by<strong> multiple basal cell carcinomas, odontogenic keratocysts, and skeletal anomalies</strong>. It is associated with <strong>mutations in the PTCH1 gene</strong>, not STK11.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Von Hippel-Lindau syndrome:&nbsp;</span></span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Von Hippel-Lindau syndrome </strong>is a <strong>hereditary cancer </strong>syndrome associated with a variety of tumors, including<strong> hemangioblastomas, clear cell renal cell carcinoma, and pheochromocytomas. </strong>It is related to mutations in the <strong>VHL gene</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Peutz-Jeghers syndrome </strong>is an <strong>autosomal dominant disorder </strong>associated with <strong>gastrointestinal polyps and mucocutaneous pigmentation, </strong>due to mutations in the<strong> STK11 gene</strong>, and it elevates the<strong> risk of multiple cancers</strong>.</span></span></span></span></p>",
      "correct_choice_id": 54628,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14261,
      "choices": [
        {
          "id": 57005,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum ferritin is decreased</span></span></span></p>"
        },
        {
          "id": 57006,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced hepcidin levels</span></span></span></p>"
        },
        {
          "id": 57007,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transferrin saturation is decreased</span></span></span></p>"
        },
        {
          "id": 57008,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total iron binding capacity is increased</span></span></span>​​​​​</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 45-year-old woman with a history of rheumatoid arthritis presents with fatigue and pallor. Her blood tests show mild anemia. Additional laboratory tests are ordered to determine the cause of her anemia. Which of the following laboratory findings is most consistent with a diagnosis of anemia of chronic disease?</span></span></span></span></span></p>",
      "unique_key": "Q6289357",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578794,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Transferrin saturation is decreased </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anemia of chronic disease (ACD), </strong>also known as<strong> anemia of inflammation</strong>, is a type of anemia that occurs in the setting of <strong>chronic inflammatory conditions, infections, or malignancies. </strong>It is characterized by disturbances in<strong> iron metabolism</strong>. The correct laboratory findings for the diagnosis of <strong>anemia of chronic disease </strong>are:</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Transferrin saturation </strong>is<strong> decreased </strong>in anemia of chronic disease due to<strong> limited availability of iron for erythropoiesis, </strong>even though <strong>iron stores are often adequate.</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased hepcidin levels </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transferrin saturation is decreased:</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Serum ferritin is increased </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total iron-binding capacity (TIBC) is decreased </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:33px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; In iron deficiency anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, <strong>serum ferritin, </strong>which reflects body<strong> iron stores, is decreased. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hepcidin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> levels are typically <strong>increased in anemia of chronic disease </strong>because it is an inflammatory marker that <strong>blocks the release of iron </strong>from body stores, contributing to the anemia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. In anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of chronic disease,<strong> TIBC </strong>is usually <strong>normal or decreased</strong>, <strong>not increased</strong>, because the <strong>body&#39;s iron is sequestered </strong>due to<strong> inflammation </strong>and is<strong> not readily available for erythropoiesis.</strong></span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong><u> </u></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In <strong>anemia of chronic disease</strong>,<strong> transferrin saturation</strong> is <strong>decreased due to limited iron utilization,</strong> despite <strong>adequate or increased iron</strong> <strong>stores </strong>reflected by <strong>normal or increased serum ferritin levels.</strong></span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p658</span></span></em></strong></p>",
      "correct_choice_id": 57007,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41786,
      "choices": [
        {
          "id": 166828,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of 4 alpha chains</span></span></span></p>"
        },
        {
          "id": 166829,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of 3 alpha chains</span></span></span></p>"
        },
        {
          "id": 166830,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of 2 alpha chains</span></span></span></p>"
        },
        {
          "id": 166831,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of 1 alpha chain</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HbH is formed due to which of the following? </span></span></span></p>",
      "unique_key": "Q8500792",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578808,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Deletion of 3 alpha chains </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deletion of 3 alpha chains </strong>leads to the formation of<strong> HbH disease</strong>. HbH is composed of<strong> four beta-globin chains </strong>and is formed in response to the lack of sufficient<strong> alpha chains</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Deletion</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>of all 4 alpha chains </strong>typically results in<strong> hydrops fetalis </strong>and is usually<strong> incompatible with life</strong>; hence it does not lead to the formation of HbH.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Deletion</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>of 1</strong> <strong>alpha chain </strong>usually causes no significant clinical symptoms and is known as <strong>silent carrier state</strong>; it does not lead to HbH formation.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C: Deletion of 2</strong> <strong>alpha chains </strong>often causes a milder form of<strong> alpha thalassemia, </strong>known as<strong> alpha thalassemia trait or alpha thalassemia minor</strong>, not typically associated with the formation of HbH.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>HbH disease </strong>is caused by the <strong>deletion of three alpha-globin genes</strong>, which leads to an <strong>excess of beta-globin chains </strong>that form the <strong>abnormal hemoglobin H (beta4).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></em></strong><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 645 </span></em></strong></span></span></p>",
      "correct_choice_id": 166829,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14269,
      "choices": [
        {
          "id": 57037,
          "text": "<p><span style=\"font-size:12pt;\">Thrombosis</span></p>"
        },
        {
          "id": 57038,
          "text": "<p><span style=\"font-size:12pt;\">Leukemia</span></p>"
        },
        {
          "id": 57039,
          "text": "<p><span style=\"font-size:12pt;\">Aplastic anemia</span>​​​​​</p>"
        },
        {
          "id": 57040,
          "text": "<p><span style=\"font-size:12pt;\">Hemolysis</span>​​​​​</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is NOT a clinical presentation feature of paroxysmal nocturnal hemoglobinuria?</span></p>",
      "unique_key": "Q3645182",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578803,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Leukemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The<strong> triad of pancytopenia</strong>,<strong> thrombosis and hemolytic anemia is characteristic of PNH.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Aplastic anemia </strong>can be a presenting feature <strong>(as per Wintrobes, Hematology). </strong>We need to remem¬ber that <strong>PNH</strong> may progress to <strong>leukemia </strong>(leukaemia CAN be a complication and NOT a feature).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">While patients with <strong>PNH </strong>may have an<strong> increased risk of developing leukemia, </strong>it is not a defining feature of <strong>PNH </strong>but rather a potential late complication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Thrombosis,</strong> particularly in unusual sites such as the <strong>hepatic or cerebral veins</strong>, is a well-recognized complication <strong>of paroxysmal nocturnal hemoglobinuria (PNH)</strong> due to the<strong> increased propensity for red blood cells </strong>to activate the <strong>complement system and the coagulation cascade</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Aplastic anemia</strong> can be a presenting feature of<strong> PNH due to the associated bone marrow failure </strong>that can occur with the disease process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Intravascular hemolysis</strong> is a<strong> hallmark of PNH</strong>, caused by the <strong>increased sensitivity of red blood cells to complement due to a deficiency in GPI-anchored proteins </strong>that normally protect the <strong>cell membrane from complement activation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>PNH </strong>is characterized by<strong> hemolytic anemia, pancytopenia, and thrombosis</strong>, but<strong> leukemia is not a feature of PNH </strong>but may be a <strong>secondary complication </strong>of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10th/e p648</strong></span></p>",
      "correct_choice_id": 57038,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15318,
      "choices": [
        {
          "id": 61232,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blasts of acute myeloid leukemia are typically Su&shy;dan black negative </span></span></span></p>"
        },
        {
          "id": 61233,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blasts of acute lymphoblastic leukemia are typically myeloperoxidase positive </span></span></span></p>"
        },
        {
          "id": 61234,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low leucocyte alkaline phosphatase score is charac&shy;teristically seen in blastic phase of chronic myeloid leukemia </span></span></p>"
        },
        {
          "id": 61235,
          "text": "<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tartarate resistant acid phosphatase positivity is typically seen in hairy cell leukemia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements pertaining to leukemia is correct?</span></span></span></p>",
      "unique_key": "Q2631088",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578823,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Tartarate resistant acid phosphatase positivity is typically seen in hairy cell leukemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tartarate resistant acid phosphatase (TRAP) </strong>positivity is a hallmark feature of<strong> hairy cell leukemia (HCL). </strong>This staining helps to distinguish<strong> HCL from other lymphoproliferative disorders </strong>and is positive in the<strong> majority of HCL cases</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Blasts </strong>in<strong> acute myeloid leukemia (AML) </strong>are often<strong> Sudan black positive</strong>. This histochemical stain is used to detect the presence of <strong>myeloid granules in blasts</strong>, which are typically <strong>abundant in AML cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Blasts of acute lymphoblastic leukemia (ALL) </strong>are generally <strong>myeloperoxidase (MPO) negative</strong>. MPO is an enzyme found predominantly in<strong> myeloid cells </strong>and is used as a marker to<strong> distinguish AML (where blasts are typically MPO positive) from ALL</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>low leukocyte alkaline phosphatase (LAP) </strong>score is seen in the chronic phase of<strong> chronic myeloid leukemia (CML), </strong>reflecting the abundance of <strong>immature leukocytes. </strong>However, the <strong>LAP score </strong>often<strong> increases </strong>when <strong>CML progresses to the blast crisis phase</strong>, due to the presence of a <strong>higher </strong>proportion of <strong>mature leukocytes.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tartarate resistant acid phosphatase (TRAP) positivity </strong>is typically seen in <strong>hairy cell leukemia (HCL), </strong>which is useful for its <strong>diagnosis and differentiation</strong> from other <strong>hematologic disorders.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 604) </span></span></em></strong></p>",
      "correct_choice_id": 61235,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14270,
      "choices": [
        {
          "id": 57041,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron</span></span></span>​​​​​​</p>"
        },
        {
          "id": 57042,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B1</span></span></p>"
        },
        {
          "id": 57043,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyridoxine</span></span></span></p>"
        },
        {
          "id": 57044,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B12</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male presents with fatigue, weakness, and pallor. Laboratory investigations reveal a microcytic, hypochromic anemia. Peripheral blood smear shows microcytic red blood cells, and bone marrow biopsy confirms the presence of ringed sideroblasts. The patient does not have a history of significant alcohol consumption. Which of the following treatments is most likely to improve the anemia in this patient?</span></span></span></p>",
      "unique_key": "Q5465632",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578804,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Pyridoxine</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sideroblastic anemia </strong>is a type of anemia characterized by the presence of <strong>ringed sideroblasts </strong>in the bone marrow. It can be either <strong>inherited (genetic) or acquired. Acquired sideroblastic anemia </strong>is often associated with<strong> myelodysplastic syndromes (MDS) a</strong>nd can respond to treatment with <strong>pyridoxine (vitamin B6).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyridoxine </strong>is a cofactor for the enzyme <strong>ALA synthase, </strong>which is involved in<strong> heme synthesis</strong>. <strong>Pyridoxine-responsive anemias</strong>, including some<strong> sideroblastic anemias</strong>, can show<strong> improvement </strong>with <strong>vitamin B6 </strong>supplementation.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. iron supplementation is used</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> for<strong> iron deficiency anemia, </strong>which typically does not feature ringed sideroblasts. In <strong>sideroblastic anemia</strong>, there is usually<strong> adequate or increased iron in the body</strong>, but it&#39;s not properly incorporated into hemoglobin.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.Thiamine deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>does not </strong>typically cause<strong> sideroblastic anemia</strong>, so supplementation<strong> would not address </strong>the underlying <strong>pathophysiology </strong>in this case.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Vitamin B12 deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> causes <strong>megaloblastic anemia</strong>, not typically <strong>sideroblastic anemia, </strong>so this would <strong>not be the</strong> <strong>treatment of choice </strong>for a patient with<strong> ringed sideroblasts</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sideroblastic anemia </strong>can be responsive to <strong>pyridoxine supplementation, </strong>especially when <strong>ringed sideroblasts </strong>are observed on <strong>bone marrow biopsy </strong>and the patient <strong>does not </strong>have a history of conditions that could <strong>cause secondary sideroblastic anemia</strong>, such as <strong>alcoholism or lead poisoning.</strong></span></span></p>",
      "correct_choice_id": 57043,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13660,
      "choices": [
        {
          "id": 54601,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alcoholic cirrhosis</span></span></span></span></p>"
        },
        {
          "id": 54602,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma colon</span></span></span></span></p>"
        },
        {
          "id": 54603,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma prostate</span></span></span></span></p>"
        },
        {
          "id": 54604,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emphysema</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A physician is considering the differential diagnoses for a patient&#39;s elevated serum tumor marker levels. Carcinoembryonic antigen (CEA) is known to be elevated in various malignancies and benign conditions. Which of the following conditions is NOT typically associated with an elevated CEA level?</span></span></p>",
      "unique_key": "Q2492802",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578826,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Carcinoma prostate</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostate specific antigen (PSA) is elevated in carcinoma prostate </span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma of the prostate</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>CEA </strong>is<strong> not a marker </strong>for <strong>prostate cancer</strong>. Instead, <strong>prostate-specific antigen (PSA) </strong>is the commonly used <strong>tumor marker </strong>for <strong>diagnosing and monitoring prostate cancer.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Alcoholic cirrhosis&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alcoholic cirrhosis can lead to<strong> elevated CEA levels. </strong>CEA is <strong>not specific </strong>for <strong>malignancy </strong>and can be raised in a variety of<strong> benign liver conditions, including cirrhosis, </strong>especially when related to <strong>alcohol use</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Carcinoma of the colon&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>CEA </strong>levels are frequently <strong>elevated </strong>in <strong>colorectal cancer </strong>and can be used as a marker for monitoring <strong>treatment response or disease </strong>recurrence after the removal of the<strong> primary tumor</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Emphysema&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic lung conditions, including emphysema, can also result in<strong> elevated CEA levels</strong>, even though these are <strong>not malignant conditions. Smoking, </strong>which is a <strong>risk factor </strong>for<strong> emphysema</strong>, can itself cause <strong>elevated CEA levels.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carcinoma of the prostate</strong>, is<strong> not </strong>associated with <strong>elevated CEA levels</strong>. Instead,<strong> prostate-specific antigen (PSA) </strong>is the<strong> tumor marker </strong>commonly elevated in <strong>prostate cancer</strong>.<strong> CEA </strong>is used primarily for<strong> monitoring colorectal cancer </strong>and can be <strong>elevated </strong>in various <strong>benign conditions</strong>, including<strong> liver and lung diseases</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-154619.jpg\" style=\"height:348px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran pathologic basis of disease 10th edition page: 336</span></span></strong></span></span></p>",
      "correct_choice_id": 54603,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14266,
      "choices": [
        {
          "id": 57025,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyanocobalamin deficiency</span></span></span></p>"
        },
        {
          "id": 57026,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Folic acid deficiency</span></span></span></p>"
        },
        {
          "id": 57027,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiamine deficiency</span></span></span></p>"
        },
        {
          "id": 57028,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Riboflavin deficiency</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old female presents with fatigue, weakness, and shortness of breath. Laboratory investigations reveal macrocytic anemia, and the FIGLU test is conducted to assess the etiology. FIGLU test is done for: </span></span></span></p>",
      "unique_key": "Q5704196",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578799,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Folic acid deficiency </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B:</span></span></strong> </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Folate deficiency can also cause<strong> macrocytic anemia</strong>. An <strong>elevated urinary FIGLU (formiminoglutamic acid) </strong>test indicates an<strong> inability to metabolize FIGLU </strong>due to<strong> insufficient folate</strong>, which is needed for its<strong> conversion to glutamic acid</strong></span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A. Vitamin B12</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> deficiency can lead to <strong>macrocytic anemia </strong>and is usually confirmed by<strong> low serum levels of B12 or elevated serum methylmalonic acid and homocysteine levels</strong>, not typically with a FIGLU test.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C. Deficiency</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> of<strong> thiamine </strong>leads to conditions like<strong> beriberi or Wernicke-Korsakoff syndrome</strong>, not typically associated with macrocytic anemia or a positive FIGLU test.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. Riboflavin</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> deficiency is associated with symptoms such as <strong>angular stomatitis and glossitis, </strong>but not usually with macrocytic anemia, and it does not cause elevated FIGLU levels.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong> </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">In patients with <strong>unexplained macrocytic anemia,</strong> a <strong>positive FIGLU test </strong>in the urine indicates a<strong> deficiency in folate</strong>. FIGLU is a </span></span></span><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">biomarker </span></span></em></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>for </strong><em><strong>intracellular levels of folate</strong>. </em></span></span></p>",
      "correct_choice_id": 57026,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13678,
      "choices": [
        {
          "id": 54673,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gene amplification</span></span></span></span></p>"
        },
        {
          "id": 54674,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosomal translocation</span></span></span></span></p>"
        },
        {
          "id": 54675,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Point mutation </span></span></span></span></p>"
        },
        {
          "id": 54676,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gene deletion</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient is diagnosed with a malignancy that is associated with an overexpression of the c-Myc gene. Which of the following is the most likely mechanism of this overexpression? </span></span></p>",
      "unique_key": "Q3401000",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578842,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Gene amplification</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gene amplification </strong>results in<strong> multiple copies of a gene</strong>, leading to<strong> overexpression of the gene product</strong>. This mechanism is frequently responsible for the<strong> increased levels of the c-Myc protein</strong> in various cancers, as it increases the<strong> transcription of genes</strong> involved in<strong> cell growth and proliferation.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Chromosomal translocation:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While chromosomal translocations can result in <strong>c-Myc overexpression</strong>, such as the <strong>translocation seen in Burkitt lymphoma (t(8;14),</strong>&nbsp;it is less common than gene amplification for the <strong>overexpression of c-Myc </strong>in a broader range of malignancies.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Point mutation:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Point mutations can <strong>activate oncogenes </strong>or <strong>inactivate tumor suppressor genes, </strong>but they are not typically associated with the <strong>overexpression of c-Myc. Instead</strong>, they might alter the function of the resulting protein.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Gene deletion:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Gene deletion generally leads to a<strong> loss of gene function </strong>and is more commonly associated with <strong>tumor suppressor genes </strong>rather than<strong> proto-oncogenes like c-Myc. Deletion would not </strong>result in<strong> overexpression </strong>but rather in reduced expression or<strong> loss of function.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gene amplification</strong> is a common mechanism for <strong>overexpression of the c-Myc gene </strong>in various malignancies, leading to <strong>increased cell</strong> <strong>growth and proliferation </strong>due to the <strong>extra copies of the gene </strong>being <strong>transcribed.</strong></span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>C-myc gene is a proto-oncogene</strong> that codes for a<strong> transcription factor </strong>involved in <strong>cell proliferation and differentiation</strong>. <strong>Overexpression of c-Myc </strong>is seen in many malignancies, and it is often due to <strong>gene amplification, </strong>which results in an<strong> increased number of copies of the gene</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chromosomal translocations </strong>can also<strong> lead to c-Myc overexpression, </strong>but they are <strong>less common.</strong></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 54673,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13667,
      "choices": [
        {
          "id": 54629,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of PD1 receptor on T-cells </span></span></span></span></p>"
        },
        {
          "id": 54630,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Upregulation of expression of PDL1 </span></span></span></span></p>"
        },
        {
          "id": 54631,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Induction of galectin</span></span></span></span></p>"
        },
        {
          "id": 54632,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Induction of regulatory T-cells</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following mechanisms does not lead to immune evasion by the tumor cells?</span></span></p>",
      "unique_key": "Q1562625",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578833,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Inhibition of PD1 receptor on T-cells</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of<strong> PD-1 receptor (Programmed death -1 receptor) </strong>on T cells causes activation of<strong> immunity against the tumor cells</strong>, not evasion.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>PD-1 receptors present on T cells inhibit T-cell activation. </strong>This allows tumors to <strong>evade the host immunity </strong>by the <strong>upregulation </strong>of the expression of factors like <strong>PD-L1 and PD-L2, which act on PD-1 receptors.</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inhibiting the PD1 receptor on T cells </strong>actually leads to the <strong>activation of the immune response against tumor cells.</strong> This is the basis for some of the <strong>cancer immunotherapies,</strong> which <strong>block PD1 </strong>to prevent the<strong> tumor cells </strong>from <strong>evading the immune system.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Upregulation of expression of PDL1:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tumor cells often upregulate PD-L1, </strong>which binds to the <strong>PD1 receptor on T cells,</strong> leading to the<strong> inhibition of the immune response</strong> against the<strong> tumor,</strong> effectively allowing the <strong>tumor to evade the immune system.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Induction of galectin&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tumor cells can induce <strong>galectins,</strong> which are<strong> beta-galactoside-binding proteins</strong> that can <strong>negatively regulate T-cell apoptosis</strong>, affect<strong> T-cell receptor signaling, </strong>or contribute to the creation of an<strong> immunosuppressive tumor microenvironment, facilitating immune evasion</strong>.</span></span></span></span></p>\r\n\r\n<p>;<span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Induction of regulatory T-cells:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tumors </strong>may induce <strong>regulatory T cells (Tregs), </strong>which suppress the activation of the immune system and maintain<strong> tolerance to self-antigens, </strong>thus aiding in <strong>tumor immune evasion.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inhibition of the PD1 receptor on T cells does not </strong>lead to <strong>immune evasion</strong> by tumor cells; rather, it <strong>activates the immune response</strong> against the <strong>tumor. PD1 receptor</strong> inhibition is a strategy used in <strong>cancer immunotherapy</strong> to overcome <strong>tumor-induced immune</strong> <strong>suppression.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran pathologic basis of disease 10th edition page: 312</span></span></strong></span></span></p>",
      "correct_choice_id": 54629,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14265,
      "choices": [
        {
          "id": 57021,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microcytic hypochromic anemia</span></span></span></p>"
        },
        {
          "id": 57022,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickled red cells</span></span></span></p>"
        },
        {
          "id": 57023,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia occurs after 3-4 years of poor absorption</span></span></span></p>"
        },
        {
          "id": 57024,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Development of polycythemia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 52-year-old male with a history of strict vegetarianism presents with weakness and paresthesias. A CBC shows macrocytosis, and his serum vitamin B12 level is low. Which of the following is most consistent with the pathophysiology of his condition?</span></span></span> </span></span></p>",
      "unique_key": "Q6120876",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578798,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Anemia occurs after 3-4 years of poor absorption </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C:</span></span></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Because the<strong> liver stores several years</strong>&#39; worth of<strong> vitamin B12</strong>, it can take years of <strong>inadequate dietary intake </strong>before clinical symptoms of <strong>vitamin B12 deficiency anemia</strong> develop.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> <strong>Microcytic hypochromic anemia </strong>is typically associated with<strong> iron deficiency, thalassemia, </strong>or other disorders of <strong>hemoglobin synthesis, </strong>not with <strong>vitamin B12 deficiency</strong>.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> <strong>Sickled red cells </strong>are characteristic of<strong> sickle cell anemia</strong>, a <strong>genetic disorder </strong>caused by a<strong> mutation in the hemoglobin gene</strong>, not related to vitamin B12 absorption.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong> Polycythemia </strong>refers to an <strong>increased concentration of hemoglobin in the blood</strong>, typically not related to vitamin B12 deficiency. Instead,<strong> vitamin B12 deficiency </strong>would lead to a <strong>decrease in red cell production </strong>due to <strong>maturation failure</strong>.</span></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong> </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">When considering a diagnosis of<strong> megaloblastic anemia due to vitamin B12 deficiency, </strong>significant <strong>hepatic stores of vitamin B12 </strong>can <strong>delay the onset of anemia for several years </strong>in patients with<strong> poor dietary intake</strong>. </span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <em>Robbins 10<sup>th</sup>/ 651-2</em></span></span></strong></p>",
      "correct_choice_id": 57023,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14271,
      "choices": [
        {
          "id": 57045,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in reduced glutathione</span></span></span></p>"
        },
        {
          "id": 57046,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in NADPH</span></span></span></p>"
        },
        {
          "id": 57047,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased in lipid peroxidation</span></span></span></p>"
        },
        {
          "id": 57048,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased RBC membrane damage</span></span></span>​​​</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old African American male presents to the emergency room with jaundice and dark urine after taking a sulfa drug for a urinary tract infection. He has a past medical history of a similar episode after eating fava beans. His labs reveal hemolytic anemia. Which of the following is NOT a consequence of the enzyme deficiency this patient most likely has?</span></span></span></p>",
      "unique_key": "Q6449129",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578806,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Decreased RBC membrane damage </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>G6PD deficiency </strong>is associated with <strong>decrease in reduced glutathione and decreased NADPH. </strong>It is associated with<strong> <em>increased lipid peroxidation </em></strong>and <strong><em>more RBC membrane damage.</em></strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Decreased red blood cell membrane damage </strong>is<strong> not </strong>associated with <strong>G6PD deficiency.</strong> In fact, the <strong>lack of NADPH </strong>leads to increased <strong>oxidative stress </strong>and thus <strong>increased membrane damage</strong>, causing <strong>hemolysis</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. In G6PD deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, there is a <strong>decrease in reduced glutathione </strong>due to <strong>insufficient NADPH</strong>, leading to <strong>decreased ability to neutralize oxidative stress </strong>in red blood cells.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. G6PD deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> results in a<strong> decrease in NADPH production</strong>, a critical factor in maintaining the <strong>reduced state of glutathione.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Without enough</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> reduced glutathione</strong>, red blood cells are <strong>more susceptible to oxidative stress</strong>, leading to increased<strong> lipid peroxidation and membrane damage</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Decreased red blood cell membrane </strong>damage is<strong> not </strong>associated with <strong>G6PD deficiency.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p640 </span></span></em></strong></p>",
      "correct_choice_id": 57048,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14278,
      "choices": [
        {
          "id": 57073,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TIBC &uarr; </span></span></span></p>"
        },
        {
          "id": 57074,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S. Iron &uarr;</span></span></span></p>"
        },
        {
          "id": 57075,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BM iron &darr;</span></span></span></p>"
        },
        {
          "id": 57076,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S. ferritin &uarr;</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old man with a history of rheumatoid arthritis presents with fatigue and exertional dyspnea. Laboratory tests show a mild anemia with a hemoglobin of 10 g/dL. Further workup reveals the following: serum ferritin is elevated, total iron-binding capacity (TIBC) is decreased, serum iron is reduced, and transferrin saturation percentage is decreased. Which laboratory finding is most characteristic of the anemia of chronic disease?</span></span></span></p>",
      "unique_key": "Q2594472",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578811,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. S. ferritin &uarr; </span></em></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anemia of chronic disease </strong>is characterized by <strong>increased serum ferritin levels, decreased Total Iron Binding Capacity (TIBC), reduced serum iron, and a decreased percentage saturation of transferrin.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Serum ferritin </strong>is an <strong>acute-phase reactant </strong>and can be <strong>increased in anemia of chronic disease</strong>, reflecting the <strong>body&#39;s iron stores </strong>which are sequestered due to<strong> inflammatory cytokines.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. TIBC is typically</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> increased </strong>due to the body&#39;s attempt to<strong> increase iron binding capacity </strong>in response to<strong> low iron stores</strong>, which is not the case in anemia of chronic disease.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Anemia of chronic disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically presents with <strong>decreased serum iron due to sequestration of iron </strong>within <strong>macrophages and hepatocytes</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. In anemia of chronic disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, bone marrow<strong> iron stores </strong>are usually <strong>normal or increased</strong>, not decreased.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most characteristic laboratory finding in <strong>anemia of chronic disease </strong>is<strong> increased serum ferritin, </strong>reflecting <strong>sequestered iron stores </strong>that are not available for<strong> effective erythropoiesis despite the body </strong>having <strong>adequate or increased total iron.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Robbins 10<sup>th</sup>/ 659 </span></span></strong></p>",
      "correct_choice_id": 57076,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13642,
      "choices": [
        {
          "id": 54529,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stimulation of apoptosis</span></span></span></span></p>"
        },
        {
          "id": 54530,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of angiogenesis</span></span></span></span></p>"
        },
        {
          "id": 54531,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of cell cycle arrest </span></span></span></span></p>"
        },
        {
          "id": 54532,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Promotion of cell proliferation</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old man presents to the emergency department with persistent abdominal pain and diarrhea. CT scan reveals the presence of a tumor in the pancreas. Biopsy confirms the diagnosis of pancreatic adenocarcinoma. Genetic testing reveals a mutation in the KRAS proto-oncogene. Which of the following best describes the role of KRAS in this case?</span></span></span></span></p>",
      "unique_key": "Q1479544",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578815,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Promotion of cell proliferation</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KRAS&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>proto-oncogene</strong> that encodes for a protein involved in <strong>cell signaling pathways </strong>that regulate<strong> cell growth and division</strong>. <strong>Mutations in KRAS </strong>can lead to the<strong> activation of these pathways, promoting cell proliferation and survival</strong>. <strong>KRAS mutations </strong>are common in<strong> pancreatic adenocarcinoma </strong>and are associated with a <strong>poorer prognosis</strong></span></span></span></span></p>",
      "correct_choice_id": 54532,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15328,
      "choices": [
        {
          "id": 61272,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M1</span></span></p>"
        },
        {
          "id": 61273,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M3</span></span></p>"
        },
        {
          "id": 61274,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M2</span></span></p>"
        },
        {
          "id": 61275,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">AML with gum infiltration and hepatosplenomegaly is most likely associated with which of the following subtypes of AML?</span></span></span></p>",
      "unique_key": "Q2333307",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578834,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) M4<em> </em></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(M4 - Acute Myelomonocytic Leukemia):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> M4 </strong>subtype includes features of <strong>both myeloblastic and monocytic lineage. </strong>The monocytic component has a predilection for <strong>tissue infiltration, </strong>such as <strong>gum hypertrophy and skin involvement (leukemia cutis), </strong>making this <strong>subtype more</strong> likely to present with<strong> gum infiltration and hepatosplenomegaly.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: (M1 - Acute Myeloblastic Leukemia without maturation):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> M1 subtype is characterized by a <strong>proliferation of myeloblasts without </strong>significant<strong> differentiation</strong>. While<strong> organomegaly can occur</strong>, M1 is<strong> not </strong>typically associated with <strong>gum infiltration.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: (M3 - Acute Promyelocytic Leukemia):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> M3 subtype </strong>is unique due to its association with the<strong> t(15;17) translocation </strong>and the <strong>PML-RARA fusion gene</strong>. It can present with <strong>disseminated intravascular coagulation (DIC),</strong> but <strong>gum infiltration</strong> is<strong> less </strong>characteristic of <strong>M3</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (M2 - Acute Myeloblastic Leukemia with maturation):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>M2 </strong>subtype shows some <strong>degree of myeloid maturation</strong>. It can occasionally involve<strong> extramedullary sites</strong>, but<strong> gum infiltration and hepatosplenomegaly </strong>are <strong>more typical of AML with monocytic differentiation</strong>, such as <strong>M4 and M5</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acute Myelomonocytic Leukemia (M4) </strong>is commonly associated with extramedullary manifestations such as <strong>gum infiltration and hepatosplenomegaly </strong>due to the<strong> infiltrative nature of the monocytic component </strong>of the leukemia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 618) </span></span></em></strong></p>",
      "correct_choice_id": 61275,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41787,
      "choices": [
        {
          "id": 166832,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stability</span></span></span></p>"
        },
        {
          "id": 166833,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Function</span></span></span></p>"
        },
        {
          "id": 166834,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affinity</span></span></span></p>"
        },
        {
          "id": 166835,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Solubility</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is affected in sickled hemoglobin; HbS? </span></span></span></p>",
      "unique_key": "Q5216378",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578812,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Solubility </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Solubility </strong>is the property most affected by the <strong>mutation causing HbS</strong>. Under<strong> deoxygenated </strong>conditions,<strong> HbS polymerizes, </strong>leading to the formation of<strong> insoluble fibers </strong>that deform the <strong>red blood cells into a sickle shape</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Stability</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> refers to the <strong>hemoglobin molecule&#39;s resistance to denaturation and degradation</strong>. While HbS can be less stable under deoxygenating conditions, this is not the primary issue.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Option B. Function pertains</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> to the <strong>ability </strong>of hemoglobin to<strong> carry oxygen</strong>. HbS can still <strong>carry oxygen</strong>, but the sickling process can hinder its release to tissues.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Affinity refers</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> to the<strong> hemoglobin&#39;s ability </strong>to<strong> bind oxygen</strong>. <strong>HbS </strong>has a <strong>slightly different oxygen</strong> affinity compared to normal hemoglobin, but again, this is not the main problem.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sickle cell hemoglobin (HbS) </strong>is primarily characterized by <strong>reduced solubility </strong>under<strong> deoxygenated </strong>conditions, leading to <strong>polymerization and sickling </strong>of red blood cells. This results in<strong> vaso-occlusive crises and chronic hemolytic anemia.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 638</span></span></em></strong></p>",
      "correct_choice_id": 166835,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14276,
      "choices": [
        {
          "id": 57065,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of enzymes involved in heme biosynthesis</span></span></span></p>"
        },
        {
          "id": 57066,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Binding of lead to transferrin, inhibiting the trans&shy;port of iron</span></span></span></p>"
        },
        {
          "id": 57067,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Binding of lead to cell membrane of erythroid pre&shy;cursors.</span></span></span></p>"
        },
        {
          "id": 57068,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Binding of lead to ferritin inhibiting their break&shy;down into hemosiderin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pathogenesis of hypochromic anemia in lead poisoning is due to:</span></span></span></p>",
      "unique_key": "Q4755220",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578809,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Inhibition of enzymes involved in heme bio&shy;synthesis </span></em></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pathogenesis of<strong> hypochromic anemia </strong>in <strong>lead poisoning </strong>is primarily due to the<strong> inhibition of enzymes </strong>involved in <strong>heme biosynthesis</strong>.<strong> Lead interferes </strong>with several enzymes in the<strong> heme synthesis pathway</strong>, including<strong> aminolevulinic acid dehydratase (ALAD) and ferrochelatase</strong>. This interference leads to a<strong> decrease in the production of heme </strong>and,<strong> subsequently, hemoglobin.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Lead</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> does not bind to transferrin directly</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. While lead can affect</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>cell membrane</strong>s, the primary mechanism of<strong> hypochromic anemia </strong>in lead poisoning is related to its impact on <strong>enzymes involved in heme biosynthesis, </strong>not direct binding to cell membranes.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Lead does not directly</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> bind to<strong> ferritin to inhibit their breakdown. </strong>The primary effect is on<strong> heme synthesis enzymes.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The primary pathogenesis of <strong>hypochromic anemia in lead poisoning </strong>involves the <strong>inhibition of enzymes necessary </strong>for<strong> heme biosynthesis</strong>, such as <strong>aminolevulinic acid dehydratase (ALAD) and ferrochelatase, </strong>leading to reduced <strong>heme and hemoglobin production.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 411, Tejinder Singh 1st/147</span></strong></span></span></p>",
      "correct_choice_id": 57065,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14313,
      "choices": [
        {
          "id": 57213,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Yellowing of eyes and sclera</span></span></span></p>"
        },
        {
          "id": 57214,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased LDH</span></span></span></p>"
        },
        {
          "id": 57215,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in haptoglobin</span></span></span></p>"
        },
        {
          "id": 57216,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low reticulocyte count</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with fatigue, pallor, and dark urine. Laboratory tests reveal anemia with increased bilirubin levels. Which of the following laboratory findings is inconsistent with a diagnosis of hemolytic anemia?</span></span></span></p>",
      "unique_key": "Q3189646",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578837,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Low reticulocyte count</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Haemolytic anaemia </strong>is characterised by the <strong>increased reticulocyte count, splenomegaly (especially extravascular hemolysis) </strong>and <strong>increased concentration of bilirubin and urobilinogen</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;A<strong> low reticulocyte count </strong>would be unusual in <strong>hemolytic anemia </strong>because the<strong> bone marrow </strong>typically responds to anemia by <strong>increasing production of reticulocytes</strong>, the<strong> immature red blood cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Yellowing of eyes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> and sclera </strong>is due to<strong> hyperbilirubinemia</strong>, which is commonly seen in<strong> hemolytic anemia </strong>as a result of <strong>increased breakdown of red blood cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Increased lactate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>dehydrogenase </strong>(LDH) is often observed in <strong>hemolytic anemia </strong>because this <strong>intracellular enzyme </strong>is released into the blood when <strong>red cells are destroyed</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. A decrease in haptoglobin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is expected in hemolytic anemia. <strong>Haptoglobin binds free hemoglobin </strong>released from <strong>lysed red blood cells</strong>, and its<strong> levels drop </strong>as it is<strong> consumed </strong>in this process.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hemolytic anemia </strong>is typically characterized by an<strong> increased reticulocyte count </strong>as the <strong>bone marrow compensates </strong>for the loss of<strong> red blood cells</strong>. A<strong> low reticulocyte count </strong>suggests an <strong>inadequate bone marrow response</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></em></strong><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Robbins 10<sup>th</sup>/ 634 </span></em></strong></span></span></p>",
      "correct_choice_id": 57216,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41782,
      "choices": [
        {
          "id": 166812,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha thalassemia</span></span></span></p>"
        },
        {
          "id": 166813,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta thalassemia</span></span></span></p>"
        },
        {
          "id": 166814,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></span></p>"
        },
        {
          "id": 166815,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6PD deficiency</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-years-old child belonging to Punjabi family with past history of blood transfusions presented with hemoglobin 3.5 g/dl, MCV &ndash; 30 fl, MCHC &ndash; 20. Peripheral smear findings of microcytic hypochromic anemia with target cell and reduced osmotic fragility. What is the he probable diagnosis of patient? </span></span></span></p>",
      "unique_key": "Q3311716",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578797,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Beta thalassemia </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Friends, let&rsquo;s get the answer of this question in a methodical manner. The clues in the question:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced values of MCV and MCHC:<strong> microcytic hypochromic anemia </strong>(G6PD deficiency is ruled out)</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age of presentation and ethnicity:<strong> 6-year-old and Punjabi ethnicity </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">History of <strong>repeated blood transfusion: </strong>in favour of <strong>thalassemia </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Osmotic fragility is reduced: </strong>in favour of thalassemia again though it may be seen in sickle cell also </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also, the hemoglobin is the question is more suggestive of <strong>severe anemia</strong> with<strong> positive</strong> <strong>history of multiple blood transfusions</strong> both being important pointers towards <strong>thalassemia major</strong>. Other ethnic groups having high prevalence of thalassemia are<strong> Punajbis, Sindhis, Gujaratis, Parsis, Begalis and Lohanas.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The above-mentioned points point to thalassemia. Since<strong> beta thalassemia is more prevalent, </strong>it is&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a better option than alpha thalassemia. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Alpha thalassemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically presents with <strong>microcytic anemia </strong>and can be<strong> severe </strong>depending on the<strong> number of gene deletions </strong>but is less common in the Punjabi population.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sickle cell anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> usually presents with<strong> normocytic anemia </strong>and not typically microcytic anemia. It can have target cells but is most commonly associated with the<strong> African population.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. G6PD deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can lead to<strong> hemolytic anemia,</strong> often episodic and related to <strong>oxidative stress,</strong> but it typically<strong> does not cause a microcytic hypochromic anemia or a reduced&nbsp;</strong></span></span></span><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCV and MCHC.</span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The&nbsp; presentation of s<strong>evere microcytic hypochromic anemia with target cells</strong>, a history of<strong> multiple blood transfusions,</strong> and <strong>reduced</strong> <strong>osmotic fragility</strong> in a child from an <strong>ethnicity with a high prevalence of thalassemia </strong>strongly suggests <strong>beta thalassemia major</strong> as the most likely diagnosis.</span></span></p>",
      "correct_choice_id": 166813,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14262,
      "choices": [
        {
          "id": 57009,
          "text": "<p><span style=\"font-size:12pt;\">Macrocytic hypochromic red cells</span></p>"
        },
        {
          "id": 57010,
          "text": "<p><span style=\"font-size:12pt;\">Target cells</span></p>"
        },
        {
          "id": 57011,
          "text": "<p><span style=\"font-size:12pt;\">Reduced poikilocytosis</span></p>"
        },
        {
          "id": 57012,
          "text": "<p><span style=\"font-size:12pt;\">Microcytic and hypochromic red cell</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 25-year-old female presented with fatiguability and dyspnea on exertion. She was found to be having a hemoglobin of 6 g/dL. What will be most likely finding in her peripheral blood smear?</span></p>",
      "unique_key": "Q7779530",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578795,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Microcytic and hypochromic red cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Microcytosis</strong> (smaller than normal red cells) and <strong>hypochromia </strong>are classic findings in <strong>iron deficiency anemia</strong>, which is consistent with the <strong>patient's symptoms and low hemoglobin.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Macrocytosis</strong> <strong>(larger than normal red cells) </strong>typically indicates a deficiency in<strong> vitamin B12 or folate</strong>, not iron. While hypochromia refers to red cells with reduced hemoglobin content, it is not typically associated with macrocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Target cells</strong> can be seen in various<strong> hemoglobinopathies, liver disease, and post-splenectomy, </strong>but they are not characteristic of iron deficiency anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Poikilocytosis</strong> refers to<strong> abnormally shaped red blood cells </strong>and is a<strong> nonspecific finding. </strong>The term \"reduced poikilocytosis\" is not typically used to describe findings in anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When evaluating a patient with anemia, particularly in the setting of<strong> fatigue and dyspnea on exertion </strong>with a significantly<strong> low hemoglobin level</strong>, finding<strong> microcytic and hypochromic red cells </strong>on the peripheral blood smear strongly suggests<strong> iron deficiency anemia</strong>.</span></p>",
      "correct_choice_id": 57012,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14277,
      "choices": [
        {
          "id": 57069,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia of chronic disease</span></span></span></p>"
        },
        {
          "id": 57070,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sideroblastic anemia</span></span></span></p>"
        },
        {
          "id": 57071,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron deficiency anemia</span></span></span></p>"
        },
        {
          "id": 57072,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalassemia minor</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old male is evaluated for anemia. Laboratory findings reveal increased serum ferritin, decreased total iron-binding capacity (TIBC), increased serum iron, and elevated transferrin saturation. Which of the following is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q4087438",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578810,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B.&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sideroblastic anemia&nbsp; </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sideroblastic anemia </strong>is characterized by <strong>increased serum ferritin levels</strong>, <strong>decreased Total Iron Binding Capacity (TIBC), increased</strong> <strong>serum iron,</strong> and an <strong>elevated percentage saturation of transferrin.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sideroblastic anemia </strong>- Characterized by<strong> ringed sideroblasts in the bone marrow,</strong> this condition leads to ineffective<strong> iron utilization,</strong> causing<strong> increased serum ferritin,</strong> <strong>decreased TIBC, increased serum iron, and elevated transferrin saturation</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Anemia of chronic disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- Typically presents with <strong>normal to increased serum ferritin</strong>, <strong>normal to decreased serum iron, and low transferrin saturation </strong>due to the <strong>sequestration of iron in macrophages</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Iron deficiency anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - Manifests with <strong>decreased serum ferritin, increased TIBC, decreased serum iron, and low</strong> <strong>transferrin saturation</strong> due to a<strong> lack of iron stores.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Thalassemia minor</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - This condition usually presents with <strong>normal iron studies </strong>and is characterized by <strong>microcytic red blood cells </strong>without an<strong> increase in iron parameters.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sideroblastic anemia </strong>is indicated by<strong> increased serum ferritin</strong>, <strong>decreased TIBC, increased serum iron, and elevated transferrin saturation</strong>, reflecting a defect in the incorporation of<strong> iron into hemoglobin </strong>within the<strong> erythroid precursors in the bone marrow</strong>.</span></span></p>",
      "correct_choice_id": 57070,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41794,
      "choices": [
        {
          "id": 166860,
          "text": "<p><span style=\"font-size:12pt;\">Duffy blood group</span></p>"
        },
        {
          "id": 166861,
          "text": "<p><span style=\"font-size:12pt;\">Sickle cell anemia</span></p>"
        },
        {
          "id": 166862,
          "text": "<p><span style=\"font-size:12pt;\">Thalassemia</span></p>"
        },
        {
          "id": 166863,
          "text": "<p><span style=\"font-size:12pt;\">G6PD deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">All of the following if present provide protection against malaria except:</span></p>",
      "unique_key": "Q2503253",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578814,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Duffy blood group</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Conditions providing protection against malaria with the reasons</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Absence</strong> of <strong>duffy blood group:</strong> duffy antigen is required for <strong>parasite to enter the RBCs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Sickle cell disease:</strong> P falciparum cannot multiply properly in the presence of<strong> HbS α and β thalassemia:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. G6 PD deficiency:</strong> G6PD is required for<strong> respiration of plasmodium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The <strong>absence of the Duffy blood group, the trait for sickle cell disease, thalassemia traits, and G6PD deficiency </strong>are all known to confer some protection <strong>against malaria </strong>due to various mechanisms that interfere with the<strong> parasite's ability to infect or survive within red blood cells</strong>. However, the<strong> Duffy blood group's absence</strong>, while protective <strong>against Plasmodium vivax</strong>, <strong>does not provide protection against P. falciparum, the most common and virulent cause of malaria.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Summary:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KESE5tw.png\" width=\"936\" height=\"364\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 403</strong></span></p>",
      "correct_choice_id": 166860,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13675,
      "choices": [
        {
          "id": 54661,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine carcinoma </span></span></span></span></p>"
        },
        {
          "id": 54662,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancreatic carcinoma </span></span></span></span></p>"
        },
        {
          "id": 54663,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchogenic carcinoma </span></span></span></span></p>"
        },
        {
          "id": 54664,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bladder carcinoma</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old patient notices spontaneously appearing and disappearing painful, linearly arranged nodules in different parts of the body. Which of the following malignancies is not associated with this clinical presentation?</span></span></span></span></p>",
      "unique_key": "Q7039975",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578839,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Bladder carcinoma</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical presentation is suggestive of <strong>migratory thrombophlebitis (Trousseau syndrome) </strong>and it is <strong>not associated </strong>with <strong>bladder carcinoma.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While<strong> bladder carcinoma </strong>can be associated with a<strong> hypercoagulable state</strong>, it is<strong> less commonly </strong>linked to<strong> Trousseau syndrome </strong>compared to the <strong>adenocarcinomas of the pancreas, lung, and gastrointestinal or gynecologic malignancies.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Uterine carcinoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine carcinoma, particularly when<strong> adenocarcinoma</strong>, can be associated with <strong>Trousseau syndrome</strong> due to its <strong>propensity to induce a hypercoagulable state</strong>, leading to<strong> venous thromboembolism.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Pancreatic carcinoma:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pancreatic carcinoma </strong>is strongly associated with <strong>Trousseau syndrome</strong>. The tumor&#39;s release of<strong> mucins and procoagulant substances </strong>can trigger a <strong>hypercoagulable state</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Bronchogenic carcinoma:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchogenic carcinoma, especially <strong>adenocarcinoma subtype,</strong> is known to produce substances that<strong> activate the coagulation system, </strong>thus it can be associated with<strong> Trousseau syndrome.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bladder carcinoma </strong>is<strong> not </strong>commonly associated with <strong>Trousseau syndrome</strong>, which is characterized by <strong>migratory thrombophlebitis </strong>and is often seen with <strong>deep-seated adenocarcinomas </strong>like those of the <strong>pancreas, lung, and other visceral organs.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran pathologic basis of disease 10th edition page: 329</span></span></strong></span></span></p>",
      "correct_choice_id": 54664,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13645,
      "choices": [
        {
          "id": 54541,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchogenic carcinoma </span></span></span></span></p>"
        },
        {
          "id": 54542,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thymoma</span></span></span></span></p>"
        },
        {
          "id": 54543,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-Hodgkin lymphoma</span></span></span></span></p>"
        },
        {
          "id": 54544,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Squamous cell carcinoma</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly female with mediastinal mass undergoes a microscopic examination showing red cell aplasia. What is the likely diagnosis?</span></span></span></span></p>",
      "unique_key": "Q9931053",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578818,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Thymoma</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct lines from Ref: Robbins. &ldquo;In addition to <strong>myasthenia gravis</strong>,<strong> thymomas </strong>may be associated with several other<strong> paraneoplastic syndromes. </strong>These include in<strong> rough order of frequency</strong>, <strong>pure red cell aplasia</strong>,<strong> hypogammaglobulinemia, </strong>and <strong>multi organ autoimmunity&rdquo;.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thymomas </strong>are<strong> tumors </strong>originating from the <strong>epithelial cells of the thymus </strong>and can be associated with various<strong> paraneoplastic syndromes</strong>, including <strong>pure red cell aplasia</strong>. This is a condition where there is a <strong>selective decrease in red blood cell precursors </strong>in the <strong>bone marrow</strong>, leading to <strong>anemia.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Bronchogenic carcinoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchogenic carcinoma refers to a<strong> type of lung cancer </strong>originating from the<strong> bronchi</strong>. Although it can present with a <strong>mediastinal mass</strong>, it is<strong> not </strong>typically associated with <strong>pure red cell aplasia</strong>, which is a <strong>reduction in the production of red blood cells</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Non-Hodgkin lymphoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-Hodgkin lymphoma is a <strong>diverse group of blood malignancies </strong>that includes any kind of <strong>lymphoma </strong>except <strong>Hodgkin&#39;s lymphomas</strong>.<strong> Types of Non-Hodgkin lymphoma </strong>can involve the <strong>mediastinum </strong>but are<strong> not typically </strong>associated with <strong>pure red cell aplasia.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Squamous cell carcinoma:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Squamous cell carcinoma </strong>can arise in various <strong>organs, </strong>including the lungs, but is<strong> not </strong>commonly associated with<strong> pure red cell aplasia or mediastinal masses </strong>unless it is <strong>metastatic from </strong>another <strong>primary location</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thymomas </strong>are<strong> mediastinal tumors </strong>that may be associated with <strong>paraneoplastic syndromes, </strong>including <strong>pure red cell aplasia, </strong>which is characterized by a selective<strong> decrease </strong>in<strong> red blood cell precursors.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p493</span></span></strong></span></span></p>",
      "correct_choice_id": 54542,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41785,
      "choices": [
        {
          "id": 166824,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of alpha genes</span></span></span></p>"
        },
        {
          "id": 166825,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion of beta genes</span></span></span></p>"
        },
        {
          "id": 166826,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Excess of alpha genes</span></span></span></p>"
        },
        {
          "id": 166827,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Single amino acid substitution in alpha chain</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the cause of alpha thalassemia?</span></span></span></p>",
      "unique_key": "Q5794467",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578807,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Deletion of alpha genes </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deletion of alpha genes </strong>is the primary cause of<strong> alpha thalassemia. </strong>The number of deleted genes can affect the<strong> severity of the disease</strong>; the<strong> loss of two genes </strong>causes mild disease, while the <strong>loss of all four genes leads to hydrops fetalis</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Deletion of beta</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> genes leads to<strong> beta thalassemia. </strong>This condition results from <strong>mutations in the beta-globin gene </strong>on <strong>chromosome 11</strong>, not the alpha-globin gene on chromosome 16.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Excess of alpha</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> genes <strong>does not cause alpha thalassemia. </strong>Typically, an<strong> imbalance between alpha and beta chains </strong>due to a relative lack of<strong> alpha genes </strong>is what causes <strong>thalassemias.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Single amino</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> acid substitution in the<strong> alpha chain </strong>is commonly associated with hemoglobin variants like <strong>Hemoglobin C or S, </strong>but <strong>not with thalassemia</strong>, which is a<strong> quantitative problem with globin chain production.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha thalassemia </strong>is most commonly caused by the <strong>deletion of alpha genes on chromosome 16</strong>, which leads to a<strong> quantitative reduction </strong>in the production of <strong>alpha-globin chains.</strong></span></span></span></p>",
      "correct_choice_id": 166824,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14295,
      "choices": [
        {
          "id": 57141,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasma homocysteine levels</span></span></span></p>"
        },
        {
          "id": 57142,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peripheral smear showing megaloblasts</span></span></span></p>"
        },
        {
          "id": 57143,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High value of mean cell volume</span></span></span></p>"
        },
        {
          "id": 57144,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum methylmalonic acid levels</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following test best differentiates cobalamin and folate deficiency?</span></span></span></p>",
      "unique_key": "Q3159348",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578825,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Serum methylmalonic acid levels</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Serum methylmalonic acid levels </strong>are<strong> increased </strong>specifically in <strong>cobalamin deficiency </strong>because<strong> cobalamin is a cofactor </strong>for the conversion of <strong>methylmalonic acid to succinyl CoA</strong>. In <strong>folate deficiency, methylmalonic acid levels remain normal.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Plasma homocysteine levels</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are <strong>elevated </strong>in both <strong>cobalamin (vitamin B12) and folate deficiencies,</strong> as both vitamins are involved in the <strong>metabolism of homocysteine</strong>. Therefore, it does not differentiate between the two.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Peripheral smear</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> showing <strong>megaloblasts</strong> is a feature common to both<strong> cobalamin and folate deficiencies</strong>, as both lead to <strong>impaired DNA synthesis and resultant megaloblastic anemia.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. A high mean cell volume</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (MCV) is indicative of <strong>macrocytic anemia</strong>, which can result from <strong>either cobalamin or folate deficiency</strong>. This finding is <strong>not specific </strong>to either condition.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Serum methylmalonic acid </strong>levels is one of<strong> diagnostic test </strong>that differentiates between <strong>cobalamin and folate deficiencies, </strong>since it is <strong>increased in cobalamin deficiency </strong>but remains <strong>normal in folate deficiency.</strong></span></span></p>",
      "correct_choice_id": 57144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13643,
      "choices": [
        {
          "id": 54533,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertrophy</span></span></span></span></p>"
        },
        {
          "id": 54534,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysplasia</span></span></span></span></p>"
        },
        {
          "id": 54535,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metaplasia</span></span></span></span></p>"
        },
        {
          "id": 54536,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperplasia</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman presents to her primary care physician for a routine health check-up. She has no complaints and her medical history is unremarkable. She undergoes a Pap smear as part of her cervical cancer screening. The cytology report describes disorganized growth of cells with hyperchromatic nuclei. Which of the following best characterizes the cellular changes seen in this patient&#39;s Pap smear?</span></span></p>",
      "unique_key": "Q6352577",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578816,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Dysplasia </span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pap smear </strong>having <strong>disorganised growth of the cells </strong>with <strong>hyperchromatic nuclei </strong>is suggestive of<strong> dysplasia</strong>.<strong> Carcinoma </strong>is diagnosed when <strong>abnormal mitotic figures </strong>are <strong>discovered </strong>and is called <strong>invasive </strong>when<strong> basement membrane is affected.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysplasia&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is characterized by<strong> abnormal growth and disorganization of cells</strong>, often with variations in <strong>size, shape, and orientation</strong>. The term is often used when referring to<strong> precancerous or potentially premalignant conditions</strong>. In a <strong>Pap smear, dysplastic cells with hyperchromatic (darkly staining) nuclei </strong>suggest a higher likelihood of<strong> progressing to cervical cancer, </strong>especially if<strong> abnormal mitotic figures </strong>are present.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hypertrophy:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertrophy refers to an<strong> increase in the size of cells</strong>, leading to an <strong>increase in the size of the organ</strong>. It is usually seen in response to <strong>increased demand or stimulation by hormones or growth factors</strong>.<strong> Unlike hyperplasia</strong>, hypertrophy <strong>does not involve </strong>an<strong> increase in the number of cells</strong>. An example would be the<strong> increase in muscle mass due to exercise.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Metaplasia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metaplasia is the <strong>reversible change from one type of cell to another due to abnormal stimulus</strong>, which can potentially <strong>predispose to malignancy </strong>if the stimulus<strong> persists</strong>. A classic example is <strong>Barrett&rsquo;s esophagus</strong>, where the <strong>normal squamous epithelium of the esophagus changes to a columnar epithelium </strong>in response to <strong>chronic gastric acid exposure</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hyperplasia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperplasia is <strong>an increase in the number of cells in an organ or tissue, </strong>which may subsequently<strong> increase the size of the organ or tissue. </strong>It is a response to a <strong>stimulus </strong>and is usually a <strong>controlled process</strong>. <strong>Hyperplasia </strong>can be a <strong>physiological response</strong>, such as the <strong>proliferation of glandular epithelium </strong>of the<strong> female breast at puberty or pathologic </strong>as seen in <strong>endometrial hyperplasia.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dysplasia, </strong>is a term used to describe <strong>disorganized growth of cells with varying size, shape, and orientation, </strong>often with <strong>hyperchromatic nuclei, </strong>suggestive of a <strong>precancerous state</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p719-720</span></span></strong></span></span></p>",
      "correct_choice_id": 54534,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14301,
      "choices": [
        {
          "id": 57165,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mucosal cell iron stores</span></span></span></p>"
        },
        {
          "id": 57166,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Route of administration</span></span></span></p>"
        },
        {
          "id": 57167,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Preparation administered </span></span></p>"
        },
        {
          "id": 57168,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age of the patient</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male is undergoing workup for fatigue and joint pain. His serum ferritin levels are markedly elevated, and a liver biopsy shows iron deposition. Which of the following most directly regulates iron uptake in the gut?</span></span></span></p>",
      "unique_key": "Q5609568",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578827,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Mucosal cell iron stores <em>&nbsp;</em></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mucosal cell iron stores </strong>influence the <strong>synthesis of hepcidin</strong>, a<strong> peptide hormone </strong>that regulates<strong> iron uptake </strong>by<strong> inhibiting its transport across the gut mucosa</strong>.<strong> Increased iron stores </strong>lead to <strong>increased hepcidin levels</strong>, which <strong>decreases iron absorption.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. The route of administration,</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> such as <strong>oral or parenteral</strong>, can influence the rate of <strong>iron absorption </strong>but does not directly regulate<strong> iron uptake at the molecular level</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. The preparation administered</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, for example,<strong> ferrous sulfate versus ferric gluconate</strong>, can affect the<strong> efficiency of absorption but</strong>, like the route, <strong>does not regulate the iron uptake process </strong>per se.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. The age of the patient</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can affect the <strong>demand for iron</strong>, especially during <strong>growth spurts or aging</strong>, but it is not a direct regulator of iron uptake in the gut.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mucosal cell iron stores</strong>, through their regulation of <strong>hepcidin synthesis, </strong>play a direct role in <strong>regulating iron uptake </strong>across the<strong> gut mucosa</strong>, which is crucial for maintaining <strong>systemic iron homeostasis</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Robbins 10<sup>th</sup>/ 658<em> </em></strong></span></span></p>",
      "correct_choice_id": 57165,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41783,
      "choices": [
        {
          "id": 166816,
          "text": "<p><span style=\"font-size:12pt;\">β- thalassemia</span></p>"
        },
        {
          "id": 166817,
          "text": "<p><span style=\"font-size:12pt;\">Hereditary spherocytosis</span></p>"
        },
        {
          "id": 166818,
          "text": "<p><span style=\"font-size:12pt;\">Autoimmune haemolytic anaemia</span></p>"
        },
        {
          "id": 166819,
          "text": "<p><span style=\"font-size:12pt;\">Megaloblastic anaemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">NESTROF test is a screening test for which of the following conditions?</span></p>",
      "unique_key": "Q9047769",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578800,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A.&nbsp;β- thalassemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>β-thalassemia</strong> - <strong>NESTROFT is</strong> used to<strong> screen for beta-thalassemia </strong>because red blood cells in this condition exhibit reduced<strong> fragility.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gpLLE9O.png\" width=\"968\" height=\"289\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>NESTROFT </strong>is a screening test for<strong> beta-thalassemia, </strong>which is based on the<strong> decreased osmotic fragility </strong>of red blood cells in this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The NESTROFT test (Naked Eye Single Tube Red cell Osmotic Fragility Test) is a simple, cheap screening test used especially in countries like India to screen for β-thalassemia trait (carrier state).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">How it works:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Based on the principle that RBCs in thalassemia are microcytic and hypochromic → they have a reduced osmotic fragility (more resistant to lysis in hypotonic saline).</span></li><li><span style=\"font-size:12.0pt;\">In the test:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">A single hypotonic saline solution (usually around 0.36% NaCl) is used.</span></li><li><span style=\"font-size:12.0pt;\">After incubation, if the solution remains turbid → positive test (RBCs did not lyse → likely β-thalassemia trait).</span></li><li><span style=\"font-size:12.0pt;\">If the solution becomes clear → negative test (RBCs lysed → normal).</span></li></ul></li></ul>",
      "correct_choice_id": 166816,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13646,
      "choices": [
        {
          "id": 54545,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aberrant expression of a receptor tyrosine kinase</span></span></span></span></p>"
        },
        {
          "id": 54546,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An inborn defect in DNA repair</span></span></span></span></p>"
        },
        {
          "id": 54547,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemical carcinogenesis</span></span></span></span></p>"
        },
        {
          "id": 54548,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DNA viral infection</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 8-year-old child is referred to a dermatologist for several &quot;suspicious&quot; pigmented lesions on his face and neck. Further history reveals the patient has had problems seeing out of his right eye; he is referred to an ophthalmologist, who diagnoses ocular melanoma. Based on the patient&rsquo;s symptoms, the diagnosis of xeroderma pigmentosum is considered. This condition results from?</span></span></p>",
      "unique_key": "Q5058629",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578819,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) An inborn defect in DNA repair</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xeroderma pigmentosum </strong>is a <strong>hereditary DNA defect </strong>with a <strong>deficiency </strong>in the <strong>ability to repair ultraviolet (sunlight)-induced thymine dimers</strong>. <strong>Faulty repair </strong>leads to <strong>increased sun sensitivity</strong>, with a <strong>predilection to develop skin lesions </strong>and<strong> skin cancers on exposed skin, </strong>as well as<strong> ocular melanomas. </strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Aberrant expression </strong>of the<strong> gene </strong>for a<strong> receptor tyrosine kinase</strong>, such as the<strong> Her-2/neu gene product</strong>, can cause<strong> breast cancer</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chemical carcinogens </strong>have <strong>highly reactive electrophile groups </strong>that directly<strong> damage DNA</strong>, leading to<strong> mutations and eventually cancer</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>retrovirus </strong>is responsible for the<strong> development of T-cell leukemia/lymphoma</strong>. </span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xeroderma pigmentosum </strong>is a condition resulting from a<strong> hereditary deficiency </strong>in the<strong> nucleotide excision repair pathway</strong>, leading to an <strong>inability to repair UV-induced thymine dimers</strong>, with resultant<strong> increased skin and ocular malignancies</strong>.</span></span></span></span></p>",
      "correct_choice_id": 54546,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13676,
      "choices": [
        {
          "id": 54665,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 54666,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3 and 4</span></p>"
        },
        {
          "id": 54667,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4 and 5</span></p>"
        },
        {
          "id": 54668,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are oncofetal antigens?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Alpha-fetoprotein</span></li><li><span style=\"font-size:12.0pt;\">Carcinoembryonic antigen</span></li><li><span style=\"font-size:12.0pt;\">Human chorionic gonadotropin</span></li><li><span style=\"font-size:12.0pt;\">Placental alkaline phosphatase</span></li><li><span style=\"font-size:12.0pt;\">Immunoglobulins</span></li></ol>",
      "unique_key": "Q6411814",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578840,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1 and 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA) are oncofetal antigens.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Alpha-fetoprotein</strong> is a valuable clinical aid in <strong>diagnosis, prognosis, and monitoring of the following tumors:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Primary hepatocellular carcinoma</span></li><li><span style=\"font-size:12.0pt;\">Hepatoblastoma</span></li><li><span style=\"font-size:12.0pt;\">Non-seminomatous testicular germ cell tumors</span></li><li><span style=\"font-size:12.0pt;\">Embryonal carcinoma</span></li><li><span style=\"font-size:12.0pt;\">Teratomas</span></li><li><span style=\"font-size:12.0pt;\">Choriocarcinoma</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Carcinoembryonic antigen </strong>is normally detected in the<strong> glycocalyx of fetal epithelial cells</strong>. It is useful in <strong>detection, assessing recurrence, and prognosis </strong>of the following tumors:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Adenocarcinoma of lung</span></li><li><span style=\"font-size:12.0pt;\">Colorectal carcinoma</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>CEA levels &gt;5 g/dL </strong>are noted in<strong> ascitic fluid </strong>associated with <strong>malignancy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Human chorionic gonadotropin:</strong> Not an oncofetal antigen; it is a placental hormone, elevated in choriocarcinoma, testicular tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Placental alkaline phosphatase: </strong>A placental enzyme, considered a tumor-associated antigen, but not truly oncofetal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Immunoglobulins:</strong> These are normal adult proteins; elevated in plasma cell dyscrasias (e.g., multiple myeloma), but not oncofetal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Alpha-fetoprotein and carcinoembryonic antigen </strong>are<strong> oncofetal antigens</strong>, which are expressed during<strong> fetal development and re-expressed </strong>in certain <strong>malignancies, </strong>aiding in the<strong> diagnosis, prognosis, and monitoring of these cancers.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins and Cotran pathologic basis of disease 10th edition page: 336</strong></span></p>",
      "correct_choice_id": 54668,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13672,
      "choices": [
        {
          "id": 54649,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchogenic carcinoma </span></span></span></span></p>"
        },
        {
          "id": 54650,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma of the pancreas </span></span></span></span></p>"
        },
        {
          "id": 54651,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esophageal carcinoma </span></span></span></span></p>"
        },
        {
          "id": 54652,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute myeloid leukemia</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old patient presents with loss of weight and appetite. On clinical examination, grade IV clubbing is evident. Imaging shows periosteal new bone formation and left knee joint effusion. Which of the following tumors is associated with this condition?</span></span></p>",
      "unique_key": "Q9769880",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578836,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Bronchogenic carcinoma</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical history is suggestive of<strong> hypertrophic osteoarthropathy</strong>. It is commonly associated with<strong> bronchogenic carcinoma. </strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bronchogenic carcinoma</strong>, particularly <strong>non-small cell lung cancer</strong>, is the most common cause of<strong> hypertrophic osteoarthropathy</strong>, which is characterized by<strong> periosteal new bone formation, arthritis of adjacent joints, and clubbing.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Carcinoma of the pancreas:&nbsp;</span></span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While patients with pancreatic cancer may develop<strong> paraneoplastic syndromes, hypertrophic osteoarthropathy </strong>is<strong> not </strong>typically associated with this <strong>type of malignancy.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Esophageal carcinoma:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Esophageal carcinoma </strong>can be associated with <strong>paraneoplastic phenomena </strong>including<strong> clubbing</strong>, but it is<strong> less </strong>commonly associated with <strong>hypertrophic osteoarthropathy </strong>compared to bronchogenic carcinoma.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Acute myeloid leukemia:&nbsp;</span></span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hematologic </strong>malignancies like<strong> AML </strong>are <strong>not </strong>commonly associated with<strong> hypertrophic osteoarthropathy</strong>. <strong>Paraneoplastic syndromes </strong>are more commonly associated with <strong>solid tumors.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hypertrophic osteoarthropathy </strong>is characterized by the following:</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Periosteal new bone formation</strong>, primarily at the <strong>distal ends of long bones, metatarsals, metacarpals, and proximal phalanges</strong></span></span></span></span></li>\r\n\t<li><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arthritis of the adjacent joints</span></span></span></span></strong></li>\r\n\t<li><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clubbing of the digits</span></span></span></span></strong></li>\r\n</ul>",
      "correct_choice_id": 54649,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15319,
      "choices": [
        {
          "id": 61236,
          "text": "<p><span style=\"font-size:12pt;\">TLC 4000-10000</span></p>"
        },
        {
          "id": 61237,
          "text": "<p><span style=\"font-size:12pt;\">Age between 1-10 years</span></p>"
        },
        {
          "id": 61238,
          "text": "<p><span style=\"font-size:12pt;\">Presence of testicular involvement at presentation</span></p>"
        },
        {
          "id": 61239,
          "text": "<p><span style=\"font-size:12pt;\">Presence of blasts in peripheral smear</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is having poor prognosis in ALL?&nbsp;</span></p>",
      "unique_key": "Q6229189",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578824,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Presence of testicular involvement at presenta­tion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>(Presence of testicular involvement at presentation):</strong> Testicular involvement at presentation is considered an <strong>adverse prognostic factor in ALL</strong>. It suggests<strong> extramedullary disease</strong>, which can be associated with a<strong> higher risk of relapse </strong>and may require <strong>more intensive treatment, </strong>including <strong>radiotherapy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: (TLC 4000-10000):</strong> Total leukocyte count (TLC) at presentation is an important<strong> prognostic factor in ALL</strong>. <strong>Normal or moderately elevated TLCs </strong>are generally associated with a<strong> better prognosis</strong>. A <strong>very high TLC</strong>, particularly above <strong>100,000, </strong>is typically considered a <strong>poor prognostic indicator in ALL</strong>, particularly in<strong> T-cell ALL</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B: (Age between 1-10 years):</strong> age less than 1 year or more than 10 years has&nbsp;poor&nbsp;prognosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: (Presence of blasts in peripheral smear):</strong> The presence of <strong>blasts </strong>in the peripheral blood smear is characteristic of ALL but on its own is<strong> not necessarily a poor prognostic indicator</strong>. The percentage and the<strong> total number of blasts </strong>can provide <strong>more specific prognostic information</strong>, with a <strong>higher burden </strong>sometimes indicating<strong> more aggressive disease.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The <strong>presence of testicular </strong>involvement at presentation in <strong>Acute Lymphoblastic Leukemia (ALL) </strong>is associated with a<strong> poorer prognosis </strong>due to the risk of<strong> extramedullary relapse </strong>and the need for <strong>more aggressive treatment</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Poor Prognostic Factors in ALL:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Age &lt; 1 or &gt; 10 years</span></li><li><span style=\"font-size:12.0pt;\">TLC &gt; 50,000/µL</span></li><li><span style=\"font-size:12.0pt;\">CNS or testicular involvement</span></li><li><span style=\"font-size:12.0pt;\">Philadelphia chromosome (BCR-ABL)</span></li><li><span style=\"font-size:12.0pt;\">Poor response to induction therapy</span></li><li><span style=\"font-size:12.0pt;\">Hypodiploidy</span></li></ul>",
      "correct_choice_id": 61238,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14293,
      "choices": [
        {
          "id": 57133,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyanocobalamin deficiency</span></span></span></p>"
        },
        {
          "id": 57134,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Folate deficiency</span></span></span></p>"
        },
        {
          "id": 57135,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sideroblastic anemia</span></span></span></p>"
        },
        {
          "id": 57136,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute blood loss</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient has been eating junk food regularly for few months and avoids fruits and vegetables. His hemoglobin is 9 g/dl and MCV is &gt;125 fl. What is the deficiency she would likely be having? </span></span></span></p>",
      "unique_key": "Q6112070",
      "question_audio": null,
      "question_video": null,
      "map_id": 34578822,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. &nbsp;Folate deficiency </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Folate deficiency </strong>can develop quickly with<strong> poor dietary habits and leads to megaloblastic anemia</strong>, which presents with a<strong> high MCV. </strong>Given the patient&#39;s diet <strong>devoid of fruits and vegetables</strong>, this is a <strong>probable cause</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Cyanocobalamin (Vitamin B12)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>deficiency</strong> typically develops <strong>over years due to the substantial stores in the liver</strong>. While it can cause <strong>megaloblastic anemia </strong>with a<strong> high MCV,</strong> the patient&#39;s short history of symptoms makes this less likely.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sideroblastic anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is characterized by the presence of <strong>ringed sideroblasts </strong>in the bone marrow and can be associated with certain<strong> drugs and toxins, genetic disorders</strong>, or may be<strong> idiopathic</strong>. It doesn&#39;t typically relate directly to dietary habits and usually shows a normal or increased MCV but not typically in the megaloblastic range (&gt;100 fL).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Acute blood loss would cause anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> with a<strong> low or normal MCV (microcytic or normocytic), </strong>not the high MCV (&gt;100 fL) that is typical of megaloblastic anemias. Plus, there is no history suggestive of blood loss.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Folate deficiency </strong>is the likely cause of <strong>megaloblastic anemia </strong>with a <strong>high MCV </strong>in a patient with a diet lacking in <strong>fruits and vegetables and a relatively quick onset of symptoms</strong>, as<strong> folate stores are depleted much more rapidly than vitamin B12 stores</strong>.</span></span></p>",
      "correct_choice_id": 57134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}